阳光保险成功来港IPO：秉承创业精神 坚守主业发展

26 12 月, 2022
HONG KONG, Dec 26, 2022 - (亚太商讯 via SEAPRWire.com) - 12月9日，阳光保险（06963.HK）在香港交易所挂牌上市，成为中国235家保险企业中的十家上市险企及八家传统直保上市公司之一，除众安在线外（06060.HK），也成为自中国平安（02318.HK）2004年上市后18年以来唯一上市的民营保险公司。创业精神驱动 谋高质量发展阳光保险的发展离不开创业精神的驱动，中国加入WTO后，保险业是第一个开放的行业，“发展”是那个时期的突出主题。2004年5月辞职后的张维功，带领创业团队先后奔赴中国17个省市，拜访并商谈389家企业，历时14个多月，找到了理念契合的股东，以市场化的方式筹建了阳光财险，并在此基础上成立了阳光保险集团。阳光保险原始创业期间形成的“敢于挑战、坚韧不拔”的创业精神，发展过程中积淀的坚守市场化机制、价值成长原则，奠定与形成了公司的价值主张与企业家精神，成为其日后稳步发展壮大的基因力量，推动公司持续高质量发展。经过近十八年的发展，阳光保险从单一的财产保险，发展到为拥有产险、寿险、资产管理、医疗养老等多家经营实体、产寿险均衡发展的保险集团公司。截至2022年6月，公司业务100%覆盖了中国大陆的所有省市自治区和60%以上的地区，拥有5.8万名员工、6.2万名寿险代理人和4.4万名产险代理人，2083家独家代理门店，服务了约3150万名个人客户，80万的团体客户。2007至2021年，阳光保险的原保费收入、资产规模年均复合增长率分别达到26%和30%，高于市场11个和13个百分点。成立五年，阳光保险就进入了中国500强；2021年，已位列中国企业500强的第194位和中国民营企业500强第60位。在不到18年的时间里，阳光保险已经发展成为具有相当社会与品牌影响力的企业集团。聚焦保险主业 做市场领跑者作为一家年轻的民营保险集团，阳光保险始终坚持专业、专注与价值发展不动摇。这种定力既有效地避开了行业激进时期的盲目跟进，也对冲了行业低迷时期的情绪低落，确保了公司快速健康的可持续发展。目前，阳光保险形成了产寿险均衡发展的业务格局，且寿险、产险、资管三家子公司在各自领域都表现优异，持续为集团创造价值利润。从保费收入来看，2019至2021年，阳光保险总保费收入的年复合增长率达到了7.6%，超过可比上市公司平均增速约6个百分点。2021年，公司寿险和产险的保费收入分别突破600亿和400亿，业务的比重大约6：4，整体业务结构合理均衡。2022年上半年，公司保险业务保持稳健发展，总保费收入较去年同期增长了14.3%，表现出了强大的盈利韧性。价值增长方面，2022年上半年，阳光保险的寿险新业务价值约20亿元；2021年较2020年增长4.3%，超过可比上市公司平均增速20个百分点以上。2022年半年度，阳光保险内含价值为929亿元；2021年较2020年增长15.5%，超过可比上市公司平均增速约7个百分点。正是这种长期一贯的战略定力，让阳光保险始终坚持“农民心态、工匠精神”，通过专业的经营、不断的创新和脚踏实地的实干，培育起了自身的竞争优势，实现跨越式发展。当前，保险行业正处于关键的转型变革期，阳光保险也将坚持“让人们拥有更多的阳光”的使命，凭借与生俱来的创业基因以及强大的战略定力，为客户提供更多更好的保险保障服务。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More

港股IPO成功上市 阳光保险“文化治司”贯穿发展主线

26 12 月, 2022
HONG KONG, Dec 26, 2022 - (亚太商讯 via SEAPRWire.com) - 12月9日，阳光保险集团股份有限公司（“阳光保险”或“公司”；股份代码：6963.HK）敲响上市铜锣，正式登陆港交所买卖，华泰国际、中金公司、瑞银集团及建银国际为联席保荐人。以文化建设为指引 筑牢企业动力引擎阳光保险是一家快速成长的民营保险服务集团，致力于为客户提供专业的风险保障及综合服务解决方案。成立不到3年，即完成了集团化组建，跻身当时国内第七大保险集团；成立不到5年，便跻身中国企业联合会及中国企业家协会发布的中国企业500强及中国服务业企业500强，成为了金融行业的一支新锐力量。高度重视文化建设是阳光保险迅速发展的“致胜法宝”。据了解，在公司成立之前，创业团队便用了四个月时间专门研究讨论阳光文化，并在之后的发展中始终追求 “让人们拥有更多的阳光”的使命，坚守“文化治司、文化强司”的发展方针，恪守“文化是阳光之魂，是实现公司战略的行动指南”的经营理念，在实践中持续推进文化落地。自此，文化力量逐步覆盖阳光保险整体的各领域、各业务线，形成了独具阳光特色的、体系化的企业文化指南——《阳光之道》，并逐渐成为公司日后前行的旗帜。阳光保险通过文化的建设和引领，让一批认可并坚持价值发展理念的阳光人聚集到一起，形成了一股团结的力量，使阳光保险一出世，在当时普遍粗放经营的保险市场上，呈现出鲜明而独具的特色。同时，在文化指引下，无数阳光人为公司勾勒了新增长曲线，铸就了发展动力引擎，进一步巩固了公司于业内的领先地位。聚焦保险主业 坚守发展定力稳中求进高质量发展是全面建设社会主义现代化国家的首要任务。阳光保险则始终秉承保险为民的宗旨，一如既往坚持以实业的心态做金融，坚守保险主业的发展定力，稳中求进，有效对冲行业低迷时期的经营困境。招股书数据显示，截至2022年6月30日止六个月，公司的总保费收入为人民币629.52亿元，归属于母公司股东的净利润为人民币17.27亿元。依托于聚焦保险主业、坚守发展定力的一贯坚持，阳光保险创新性实现各主要子公司交叉合作，整合内部资源优势开拓市场，在价值发展道路上形成了均衡发展的业务格局。据悉，于2019年、2020年及2021年，同时持有公司财产险及人身险保单的客户贡献的保费收入合计分别为人民币70.34亿元、人民币74.45亿元及人民币74.95亿元，占总保费收入的比例分别为8.0%、8.0%及7.4%。不难看出，重视文化建设和聚焦保险主业为阳光保险的行稳致远提供了良好助推力，构筑了厚实的护城河壁垒。成功于港交所主板挂牌的阳光保险，既是中国第79家保险企业，也是除众安这类纯互联网保险公司之外，继2004年中国平安（02318.HK）港股上市后，18年来唯一一家登陆香港资本市场的民营保险公司，且自此成为中国235家保险企业中的十家上市险企及八家传统直保上市公司之一。值得注意的是，阳光保险作为为数不多的保险上市标的，此次能够成功赴港上市，一方面体现其标的的优质性；另一方面也为保险行业的再次勃发释放了积极信号。身为保险领域的“新兴势力”，阳光保险兼具市场活力与高度发展定力，长远前景不容小觑。此外，同样期待未来有更多的保险企业加入香港资本市场！ Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More

品牌、产品、渠道、供应链全面升级，国民品牌卫龙冲刺港股

26 12 月, 2022
HONG KONG, Dec 26, 2022 - (亚太商讯 via SEAPRWire.com) - 国民辣味休闲食品卫龙要在港股上市了。卫龙可谓是国人心目中的经典辣味休闲食品，在国内市场广受欢迎，其中，卫龙辣条更是拥有广泛的群众基础，是一代国人的成长回忆。其创始人刘卫平专注辣味休闲食品领域二十年，从一根辣条开始，逐步拓展了蔬菜制品、豆制品及其他产品等辣味休闲食品组合，推出“风吃”和“亲嘴烧”系列等多种品牌，卫龙也成长为集研发、生产、加工和销售为一体的现代化辣味休闲食品企业。2022年上半年经调整净利润4.25亿，年复合增长率高达19.1%11月23日，卫龙美味全球控股有限公司（简称“卫龙”）更新聆讯资料集。摩根士丹利、中金公司和瑞银集团为联席保荐人。更新后的招股书显示，2022年上半年，卫龙业务运营及财务业绩保持相对稳定，毛利率从去年同期的36.9%提升到了38.1%；除去与首次公开发售前投资(“Pre-IPO”)有关的一次性的以股份为基础的付款等调整后，公司截至2022年6月30日止六个月经调整净利润为4.25亿元，业绩表现良好。在持续的疫情冲击下，很多行业成为疫情重灾区，卫龙能够实现稳健经营，并保持业绩相对稳定，凸显了公司的抗风险能力和经营韧性。复盘过往的业绩发展，卫龙保持了强劲的增长势头，实现了远高于行业的高复合增长率和利润率。招股书显示，2019年至2021年，卫龙营收分别为33.85亿元、41.2亿元、48亿元，2019年至2021年，卫龙总收入的年复合增长率达到19.1%，远超中国休闲食品行业同期4.2%的年复合增长率；上述同期，卫龙经调整净利润分别为6.59亿元、8.21亿元、9.08亿元，经调整后净利润率分别为19.5%、19.9%、18.9%，高于2021年中国休闲食品行业约10%的平均净利润率。2019年至2021年，卫龙的毛利率分别高达37.1%、38%、37.4%，这个毛利率水平在休闲食品行业一骑绝尘，甚至与国内众多实体行业相比也不遑多让，体现了卫龙在行业强大的竞争力。如今，卫龙已经是中国领先的辣味休闲食品企业，根据弗若斯特沙利文数据，按2021年零售额计，卫龙在中国所有辣味休闲食品企业中排名第一，市场份额达到6.2%，超过第二到第五名企业的份额总和，是第二大企业的3.9倍。品牌持续出圈，品类创新和建设富有成效在当前波动的市场大环境下，卫龙“逆势而上”，着力在品牌、产品、渠道、供应链等方面升级，新工厂陆续投产，扩大产能。品牌方面，卫龙在国内拥有广泛的消费者基础，是80后、90后小时候的亲切回忆。近年卫龙还加大年轻化、趣味化营销力度，并屡屡出圈获得消费者好感，品牌形象日益深入人心。今年的双十一，卫龙再次以“下单就是缘”的佛系品牌营销圈粉无数，既拓展了消费者群体，又能持续保持品牌热度。弗若斯特沙利文的调查资料显示，卫龙是中国知名度最高、最受消费者喜爱的辣味休闲食品品牌。同时，卫龙还是倍受年轻消费者喜爱的休闲食品品牌。根据弗若斯特沙利文的资料，95.0%的消费者年龄在35岁及以下，55.0%的消费者年龄在25岁及以下。产品方面，卫龙通过推出创新口味、升级包装设计、丰富营养价值、提升生产工艺的方式，进一步优化主要产品的消费体验，来吸引更广泛的消费者并巩固公司的市场领先地位。在发展路径上，战略性品类拓展是公司实现长期增长的动力之源，公司将聚焦于蔬菜制品、肉制品、蛋制品等休闲品类中开发更多受到欢迎的新产品。从品类创新和建设看，近年卫龙已成功拓展到蔬菜制品和豆制品等品类，并打造了魔芋爽、风吃海带、78°卤蛋等畅销产品，其中，得益于优异的口感，魔芋爽成为继卫龙大面筋之后又一爆款单品。2021年，卫龙有2个品类（即调味面制品及蔬菜制品）的年零售额超过人民币10亿元；其中4个单品（即大面筋、魔芋爽、亲嘴烧及小面筋）的年零售额均超过人民币5亿元，以魔芋爽所代表的蔬菜制品占营收的比重越来越高。此外公司还在积极进行新品研发，近期新推出全新新品“麻辣麻辣”，在研产品已超过4款，并于2023年至2025年推出新的豆制品及其他产品，包括豆制品、肉制品及代餐产品等。渠道及供应链方面，卫龙致力于销售渠道的改善，不断完善线下销售渠道，提升辣味休闲食品的可触达性。截至2022年6月30日，卫龙与超过1830家线下经销商合作，公司经销商的销售网络覆盖了中国约73.5万个零售终端。此外，由于年轻消费者在线购物需求的增加，卫龙也在加强对各大电商平台的布局，线上销售额不断增加。2019年、2020年、2021年及2022年上半年，线上渠道产生的收入分别为2.51亿元、3.82亿元、5.54亿元及2.39亿元，占比7.4%、9.3%、11.5%及10.6%。产能方面，截至2022年6月30日，卫龙在河南省拥有四个工厂，分别为漯河平平工厂、漯河卫来工厂、驻马店卫来工厂及漯河卫到工厂，且在河南省还有一个工厂（即漯河杏林工厂）的部分产线已用于试产。在扩大产能的同时，卫龙多措并举实现数字化升级，全面提升企业经营效率。公司通过打造数据化的卫龙、建立数字化的卫龙、实现智能化的卫龙三步举措，来实现“互联互通，一切业务数智化”的目标。届时，卫龙将利用大数据、人工智能、工业互联网和实时计算等技术，推动产品和服务项目、运营模式、组织及公司治理的革新，努力实现全方位的智能管理，强化卫龙竞争优势，并提高长期核心竞争力。同时，不断引进专业化高端人才，完善组织，强化核心管理力量，从而不断实现经营管理升级。获高瓴、腾讯、云锋等知名机构加持在品牌、产品、渠道、供应链、产能方面独具优势，卫龙未来发展被众多知名投资机构看好，股东阵营星光熠熠。2021年，成立20多年的卫龙首度进行融资，一举获得CPE、CWL Management XVIII Limited、高瓴、腾讯、云锋基金、红杉资本中国基金、Duckling Fund,L.P.、厚生投资、海松资本、上海泓漯的加持。众多明星股东的加持，也让市场看到卫龙未来的发展潜力，及增长信心。小结中国是全球最大的休闲食品市场之一，辣味在我国饮食习惯中历史悠久。随着经济增长及可支配收入的持续增长，露营、娱乐、办公等消费场景日益丰富，以及不断提升的消费频次，持续推动辣味休闲食品行业增长。根据弗若斯特沙利文报告，预计中国辣味休闲食品行业2021年至2026年的零售额将以9.6%的年复合增长率增长，至2026年将达到人民币2737亿元，高于同期中国非辣味休闲食品行业的零售额6.0%的年复合增长率增长。作为辣味休闲食品龙头，卫龙或将率先享受行业增长红利，取得健康可持续发展。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
全球主要医疗器械制造商业聚医疗集团之股份于香港联交所主板挂牌上市 ACN Newswire

全球主要医疗器械制造商业聚医疗集团之股份于香港联交所主板挂牌上市

23 12 月, 2022
HONG KONG, Dec 23, 2022 - (亚太商讯 via SEAPRWire.com) - 专营经皮冠状动脉介入治疗（PCI）及经皮腔内血管成形术（PTA）手术介入器械的全球主要医疗器械制造商业聚医疗集团控股有限公司（「业聚医疗」或「集团」）的股份今天于香港联合交易所有限公司（「香港联交所」）主板正式挂牌买卖，股份代号为6929。业聚医疗名誉主席兼创始人钱学雄先生(右)和董事长、执行董事兼行政总裁钱永勋先生(左)敲响铜锣，标志集团正式于香港交易所主板上市董事长、执行董事兼行政总裁钱永勋先生(右)致送纪念品予香港交易所代表业聚医疗慷慨捐赠港币三百万元予香港交易所慈善基金，获得股份代号「6929」。董事长、执行董事兼行政总裁钱永勋先生(右)向香港联交所赠予支票（由左至右）：业聚医疗集团控股有限公司：周静忠，执行董事兼业务发展主管；陈泳成，执行董事、财务总监兼公司秘书；谭丽芬，独立非执行董事；刘桂祯，执行董事兼营运总监；钱学雄，名誉董事长兼创办人；钱永勋，董事长、执行董事兼行政总裁；楼家强，独立非执行董事；陈业强，独立非执行董事关于业聚医疗集团控股有限公司业聚医疗是一家主要的全球医疗器械制造商，专门生产用于经皮冠状动脉介入治疗（PCI）及经皮腔内血管成形术（PTA）的介入器械。总部位于中国香港，业聚医疗的产品销往全球超过70个国家和地区。根据灼识咨询报告，就2021年PCI球囊的销量而言，集团亦是唯一一家总部设在中国，且在包括日本（排名第二）、欧洲（排名第四）及美国（排名第六）在内的所有主要海外PCI球囊市场排名前六的公司。此外，就2021年PTA球囊的销量而言，集团在日本市场排名第三，在美国市场排名第四。集团亦专攻冠状动脉支架产品，并积极将业务扩展至神经血管介入及结构性心脏病领域。业聚医疗现于全球拥有超过180项授权专利。集团内部研发团队有逾20年积累的产品开发经验，并已开发出世界领先的专有技术。如需了解更多详情，请访问集团官网：https://orbusneich.com/ Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More

国际化版图渐明，国轩泰国行背后的战略与考量

22 12 月, 2022
HONG KONG, Dec 22, 2022 - (亚太商讯 via SEAPRWire.com) - 12月15日，国轩新加坡公司与泰国Nuovo Plus有限公司，达成战略合作。双方拟在泰国合资建立泰国新国轩有限公司进行电池模组及Pack产品的设计、开发、制造、销售和出口，并将在泰国实现本地化生产制造与市场开拓的同时，积极探索东盟新能源市场，致力于打造电池出口东盟基地。首先为什么国轩高科要选择泰国作为这一次布局的市场呢？从整体市场规模来看，去年东南亚地区汽车生产量达到354万辆，其中泰国汽车产量为169万辆，总占比接近50%，超过了印度尼西亚，马来西亚等其他国家，由此可见泰国是东南亚地区汽车产量最高的国家，并且汽车出口量也位居前列，不但如此，泰国政府自身还推出了一系列的优惠税收激励政策。原本泰国汽车的进口关税一直很高，但是为了鼓励本土汽车制造业，当地汽车制造商可以通过泰国与其他国家的汽车公司签订贸易协议，以此来降低进口关税，同时在原材料，汽车零部件等其他方面也享受降税政策，其中重要零部件，包括电池，电机，电控，压缩机，电池管理系统等。其次从居民购买的角度出发，泰国政府还推出了一系列新能源汽车购置补贴优惠政策，给予符合条件的电动汽车约7万到15万泰铢（约合人民币1.39万-2.98万元）的价格补贴，用来鼓励居民尽快置换原有的燃油汽车，预计在政府新能源汽车优惠政策促进下，2022年其汽车销量会增至85万辆，为全球碳中和做出自身的努力。其次，从当地基础设施规划来看，泰国政府预计到2030年拥有的公共快速充电站可提供12,000个快充充电头，建立超过1400个充电站，并且泰国政府表示希望至2035年后，实现全面电气化，泰国国家电子汽车政策委员会发布总体规划分别以5年、10年、15年为期，力求打造完整的电动汽车产业链，按照计划，到2025年，泰国为政府机构和公用车队采购的所有车辆均为零排放汽车，本土制造的新车中有15％为零排放汽车。到2030年，泰国政府机构和公共部门用车全部实现零排放，本土制造的新车30％为零排放汽车。2035年，泰国本土生产的新车全部实现零排放。泰国政府希望凭借其动力成本优势和供应链系统在全球汽车产业中的竞争力，将泰国打造成东盟最大的电动汽车制造基地。可以说，国轩选择在泰国建厂，恰好赶上泰国新能源的风口。对于国轩高科，这一次的合作方选择，Nuovo Plus有限公司，隶属于PTT集团，PTT集团是一家拥有政府背景的国家能源和石油化工公司，作为一家石油化工一体化的企业，拥有三大炼油厂，11家石油化工公司，总部设在泰国首都曼谷，五百强企业，并且曾被全球财富能源效用部门评为世界最佳大型公司之一，也曾被评为年度最佳管理公司之一。所以说，对于国轩，无论是从公司实力还是公司背景，或者是对未来新能源趋势的大方向选择PTT都将成为最好的合作伙伴。在从传统能源到新能源的转型已成为大势所趋的当下，双方的合作值得期待。近年来，国轩高科不断加强全球合作。尤以与大众合作备受瞩目。作为最早布局动力电池的一批公司之一，公司在2020年与大众中国签署了合作协议，大众成为公司第一大股东。后者规划到2023年在华汽车产能超过90万辆，并且持续强化自有体系内的电池供应链安全，虽然大众在中国新能源汽车占有率略低于比亚迪和特斯拉，但是正在加速进场布局，未来发展空间巨大，在后面的战略规划当中，计划未来十年推出60种混动以及75款纯电动车型，计划在华2025年销售电动车数量达150万辆全球累计销售量达2200万辆。大众作为全球前五大汽车集团，拥有高标准，严规格的研发配套体系和全员全过程品控保证能力，通过明确分工，取长补短，严格审核把关，从各个角度去提高公司整体研发和供应链管理水平。从技术层面看双方成立了国轩大众联动项目组，由国轩高科负责材料科学和电池科学的研究技术，大众负责后端测试和一致性审核，工作分工明确，从管理层面来看，大众从采购生产制造产品品质方面，派驻多名专家及管理人员，对标大中质量管理体系，帮助公司供应和产品品质提升。在过去的2021年当中，国轩高科成为A00级别的电动车市场电池装计量及配套数量最多的企业，总电量为4.7GWh，配套数量23万台，稳坐第一梯队。同时，公司在中高端市场开拓了零跑、长城欧拉等客户，并在多款中高端车型装车，预计年内自研半固态电池也将装车某高端车型，公司客户结构已不断优化。技术方面，公司动力电池倾向于选择高性价比的磷酸铁锂，由于公司深耕磷酸铁锂技术多年，已经拥有能量密度为230Wh/kg 的磷酸铁锂电池量产能力。其次，在全球碳中和的大势前提条件之下，由于用电的供需错配，使得储能行业爆发在即，预计未来三年储能行业将有翻倍式的增长空间，公司技术领先的磷酸铁锂电池，因其经济性和安全性， 比三元锂电池更加适合储能市场，有望在未来储能赛道中占据主流路线，由于公司较早地切入了储能赛道业务，不管是供应储能电芯还是参与储能电站建设亦或是销售多款储能产品，都已经形成了成熟的产业链，目前已经与以华为为首的多家公司进行合作。近两年高锂价一直困扰着锂电池企业，所以锂资源的纵向一体化，尤其是向上布局，是众多锂电池企业盈利的关键，国轩高科对于锂资源的布局，在电池企业中表现十分领先，在锂矿方面，公司与宜春矿业成立合资公司，并且目前多个项目已经投产，预计公司在2025年建成12万吨产线，可覆盖190到200GWh电池产能。此外，在海外锂资源布局方面，公司已于2022年6月与阿根廷JEMSE公司规划在阿根廷胡胡伊省建立碳酸锂产线，建设海外原材料基地。所以在未来公司大概率不会因为锂矿资源而出现卡脖子现象，这次全产业链布局，使得动力电池生产成本稳定可控。总体来说，国轩高科和Nuovo的合作，最终目的是希望在泰国有利政策支持下，建设以“共赢“为基础的亚洲新能源汽车生态圈，从进口，出口多个方面，在亚洲地区形成规模规范效应，生态圈旨在覆盖生产制造领域、消费领域和消费者的生活领域，不仅在一定程度上可以有效地消除消费者在用车环节的顾虑，并逐渐实现与传统车在使用上的便利性，对于用户而言，无疑是最受益的一方。而站在车企的角度，建立生态圈不仅提前解决客户的用车烦恼，还可以升品牌形象与增设销售渠道，让低碳环保不仅仅再是口号。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More

优然牧业打造奶牛养殖行业ESG最佳实践 斩获金紫荆奖“最佳ESG实践上市公司”奖

22 12 月, 2022
HONG KONG, Dec 22, 2022 - (亚太商讯 via SEAPRWire.com) - 近日，由北京上市公司协会、香港中国企业协会、香港中资证券业协会、香港中国金融协会等机构共同举办，被资本市场誉为“上市公司的奥斯卡奖”的中国证券金紫荆奖颁奖典礼上，优然牧业斩获金紫荆奖“最佳ESG实践上市公司”大奖。作为全球最大的原料奶供应商，优然牧业养殖奶牛近45万头，饲料业务服务全国超过1/4的奶牛。2021年，优然牧业实现营收153.46亿元，是行业内最有实力的企业。优然牧业在行业内率先研究奶牛减碳技术、粪污综合循环利用和新能源利用等碳减排研究，并且在保护生物多样性、保障奶牛福利等可持续发展等方面做出积极贡献，打造了奶牛养殖行业ESG最佳实践，于今年9月成功加入联合国全球契约组织。目前，优然牧业已经搭建了覆盖乳业上游全产业链的碳核算模型，推进碳信息系统建设。先后承接了国家科技部与内蒙古自治区开展的“科技兴蒙”项目中的《规模化牧场养殖过程碳中和、碳减排综合技术研究与应用》，以及宁夏《奶牛养殖碳排放监测预警平台构建及低碳减排循环养殖模式示范应用》，开展低碳减排研究，推动畜牧养殖碳中和。通过奶牛营养研究降低奶牛碳排放在低碳饲料研究方面，优然牧业率先在行业内开始研究低碳且高品质饲料产品，通过体外仿生技术，评估不同生产条件下，不同品质饲料的碳排放量。公司还研发了能氮平衡技术、酶工程营养调控技术、氨基酸平衡技术等健康、低碳养殖关键技术，通过提高奶牛饲料利用率，减少奶牛瘤胃发酵过程的温室气体排放量，实现源头减碳。研究奶牛碳减排育种技术，培育低碳核心牛群作为全球最大的原奶奶供应商，优然牧业近45万头庞大的牛群如何降低碳排放，一直是其技术研究的重点。优然牧业研究建设了奶牛碳排放育种数据库，通过开展奶牛全基因组数据中甲烷等碳排放量相关的重要基因或分子标记挖掘研究，培育低碳核心牛群，并结合性控技术进行快速扩繁，达到育种改良，实现奶牛生产性能快速提升，单产达到14吨以上，打造全球领先的高产低碳牧场。实现粪污综合利用变废为宝最佳实践优然牧业自成立以来，一直坚持“种养结合”的经营模式，通过粪污综合循环利用，将奶牛养殖与牧草种植有机协同，形成绿色循环可持续发展模式。优然牧业依据南北方气候特点，自主研究与开发了全混式沼气厌氧发酵工艺和全自动智能好氧发酵工艺。牧场将粪污发酵排出的气体进行回收利用，并通过沼气发电的形式，实现能源利用，低碳减排，固态部分无害化后作为卧床垫料回填卧床。液态部分经过发酵制成有机肥还田，能够增加土壤有机质，改良土壤肥力，为优质牧草种植提供了充足的资源保障。通过养殖和种植相互促进的绿色经营模式，实现“从一棵草到一杯奶”的低碳可持续发展。利用新能源逐步实现“零碳牧场”为实现资源化高效循环利用，节能降耗，优然牧业牧场将新能源不断应用，并率先在国内运用光伏和沼气发电。其中，光伏发电项目充分利用牧场空置场地资源，铺设光伏组件，通过光伏发电可解决牧场运营40%的用电量。在中南部区域牧场还应用了沼气发电项目，仅一座万头牧场年产沼气量约625万立方，实现全量发电，年发电量可达1150万度，能够解决牧场运营60%的用电量。优然牧业通过配置光伏发电项目和沼气全量发电，推动清洁能源发电，逐步实现绿电循环的“零碳牧场”，从而实现了降低费用投入和绿电自用的双赢。以育种技术优势为生物多样性保护做贡献在保护物种与生态系统的可持续发展方面，优然牧业通过自身育种技术优势，建立了包括牛、鹿、奶山羊等动物的高效克隆技术体系，为保护内蒙古高原生物多样性与种质资源提供了技术支持。作为中国最大的奶牛育种企业，优然牧业的赛科星研究院与内蒙古大学合作建立了种质资源库，并已经收集蒙古高原地区特有、适应性强、抗病抗逆优势明显的牛、羊、马等家畜、野生动物品种资源168个、超过3万个资源样品（包括细胞、精液、胚胎等)，同时重点收集并养殖了蒙古牛、蒙古羊、蒙古马等20余种特有家畜品种，开展相关遗传与育种应用研究。后期将利用干细胞基因编辑、克隆繁育等现代生物育种技术应用，为保护生物多样性提供基础遗传物质材料和关键技术支撑。建立动物福利六大标准呵护奶牛全生命周期一直以来，优然牧业将动物福利建设作为工作核心之一，专门研究建立了奶牛福利六大标准，包括“适宜奶牛生活的舒适饲养环境”、“保证奶牛的休息、娱乐、社交、自由活动空间”、“数字化可穿戴设备监测奶牛健康，提前保健护理”、“自由采食营养、新鲜的饲料；饮水到达人饮水标准”、“应用无人智能设备,减少奶牛应激”以及“将奶牛福利标准纳入员工养殖理念和操作流程”，形成了一套完整的奶牛福利管理体系。同时借助优然牧业自主开发的智慧牧场管理系统，实时监控牧场奶牛生理特征及牧场饲养环境等各环节，对奶牛的全生命周期进行精准管理，全面提升奶牛福利。此次荣获“最佳ESG实践上市公司奖”后，优然牧业表示，未来将持续在全产业链低碳发展、节能降耗、生物多样性保护、动物福利建设等业务领域深耕，始终走绿色发展道路，通过自身努力和与社会各界地共同协作，继续为行业可持续发展贡献智慧和力量。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
市场气氛改善及大型推广活动成功推动 AEON信贷财务2022/23财年首九个月收入上升15.2％至887,400,000港元 ACN Newswire

市场气氛改善及大型推广活动成功推动 AEON信贷财务2022/23财年首九个月收入上升15.2％至887,400,000港元

21 12 月, 2022
HONG KONG, Dec 21, 2022 - (亚太商讯 via SEAPRWire.com) - AEON信贷财务（亚洲）有限公司（「AEON信贷财务」或「集团」；股份代号：00900）今天公布截至2022年11月30日止九个月之业绩（「报告期间」或「2022/23财政年度之九个月」）。于报告期间，集团的收入上升15.2%至887,400,000港元;营运溢利增长17.0％至380,700,000港元;除税后溢利上升2.9%至250,300,000港元;每股盈利增至59.77港仙（2021/22财政年度之九个月：58.09港仙）。截至2022年11月30日止三个月（「第三季度」），海外及本地消费均逐步回升。市场气氛改善，加上集团致力把握市场机遇，推动销售额大幅增长，与截至2021年11月30日止九个月（「去年同期」或「2021/22财政年度之九个月」）比较整体上升28.3%。销售额及循环信用卡及私人贷款余额整体上升带动利息收入稳健增长，收入亦因此增加。集团自2021年8月起为永旺百货提供收单服务，带动费用及佣金于报告期间整体增加25,000,000港元至94,900,000港元，亦有助推动收入增长。报告期间，作为促进业务发展的举措之一，集团推出「日本旅游签账赏」推广，以抓紧海外消费上升的机遇。此外，集团在不同媒体渠道增加曝光，以推广其品牌和产品，并为分行配备提供财务顾问服务所需的资源。保险中介业务方面，集团于第三季度与安达人寿保险有限公司（「安达人寿香港」）建立新的分销合作伙伴关系，以拓展线下及线上保险销售渠道，方便客户接触及购买到各种保险产品。至于资讯科技发展，集团继续推进新信用卡及贷款系统项目，以及更换网上会员及手机应用系统，确保新的系统按预期投入运作。在可持续发展方面，集团建立了可持续发展表现挂钩贷款框架，并签订可持续发展表现挂钩贷款协议（「该等贷款」）。该等贷款为集团首个可持续融资计划，通过将该贷款的息差与集团环境、社会和治理的关键绩效指标联系起来，加强集团对可持续发展的承诺。展望未来，随着国际旅游恢复，截至2023年2月28日止年度的第四季度（「第四季度」），航班载运力料将逐步回升，社交距离措施亦将进一步放宽，预计将带来更多销售机会，推动应收款项增长。集团将于第四季度推出多项大型推广活动，以刺激节日期间的销售增长，并满足客户在税季的需求。集团亦将利用与安达人寿香港的新合作伙伴关系产生更多协同效益，以及通过不同的保险分销渠道增加代理费收入。AEON信贷董事总经理深山友晴先生表示：「凭借我们在宣传推广及满足顾客需要的不懈努力，我们很高兴于2022/23财政年度之首九个月录得理想的业绩。展望未来，我们将继续随着市场复苏，推出各项大型推广活动，并利用我们在保险业务方面的合作关系，及开拓新商机以缔造更多元化的收入来源，为股东带来长期持续的增长。」关于AEON信贷财务（亚洲）有限公司（股份代号：00900）AEON信贷财务（亚洲）有限公司为AEON Financial Service Co., Ltd.之附属公司（东京证券交易所编号：8570）及AEON集团旗下公司，成立于1987年，并于1995年在香港联合交易所有限公司主板上市。集团主要从事消费融资业务，包括于香港签发信用卡及提供私人贷款融资、信用卡付款处理服务、保险代理及顾问业务，以及于中国内地从事小额融资业务。详情请浏览公司网址：www.aeon.com.hk。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
Heavyweights to speak as Asian Financial Forum opens conference year ACN Newswire

Heavyweights to speak as Asian Financial Forum opens conference year

19 12 月, 2022
HONG KONG, Dec 19, 2022 - (ACN Newswire via SEAPRWire.com) - The 16th Asian Financial Forum (AFF), organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), will be held on 11 and 12 January next year in hybrid format. Ban Ki-Moon, eighth Secretary-General of the United Nations and more policymakers and business leaders will deliver keynote speeches at AFF 2023.Helen Clark, Former Prime Minister of New ZealandChristiana Figueres, Co-Founder of Global Optimism and Former Executive Secretary of the United Nations Framework Convention on Climate ChangeThemed "Accelerating Transformation: Impact - Inclusion - Innovation", the Forum will include addresses from more than 100 global business leaders, policymakers, financial and wealth management experts, entrepreneurs, tech giants and economists who will share their views on issues related to global finance, economy, trade and sustainability. The Forum will also provide a platform to connect participants for business and investment opportunities to strengthen Hong Kong's status as an international financial centre. As the restrictions on arrivals have been relaxed, more international business travellers are expected to visit Hong Kong and participate in international conferences. To promote the vitality of the city, the HKTDC has curated a variety of exclusive benefits for AFF delegates from overseas, enriching their stay beyond the two-day forum.Speakers include the Former Secretary-General of the United Nations (UN), Former Prime Minister of New Zealand and Former Executive Secretary of the UN Framework Convention on Climate ChangeAs the premier financial and business forum and the first large-scale business exchange event kicking off the new year, AFF assembles more than 100 heavyweight thought leaders to examine ways to formulate better business strategies and develop a blueprint for sustainable growth after a turbulent 2022, and explore how global corporates can work together to create a resilient economic landscape through innovation and inclusion. This year's forum draws a number of policymakers and business leaders to share their views, including the following three eminent keynote speakers:- Ban Ki-moon, eighth Secretary-General of the UNBan Ki-moon served as Secretary-General of the UN between 2007 and 2016. During his tenure, he focused on the response to global challenges, from climate change and economic upheaval to pandemics and food and energy crisis. He will deliver his keynote address and share his insights on coping with global challenges and promoting sustainable development with multilateral cooperation on the first day of Forum (11 January).- Helen Clark, Former Prime Minister of New ZealandHelen Clark was the Prime Minister of New Zealand from 1999 to 2008. Throughout her tenure, she engaged widely in policy development and advocacy across the international, economic, social and cultural spheres. She will deliver her keynote address under the theme of equality and diversity on the second day of Forum (12 January).- Christiana Figueres, Co-founder of Global Optimism and Former Executive Secretary of the UN Framework Convention on Climate ChangeChristiana Figueres is an internationally recognised leader fostering climate action. As the Executive Secretary of the UN Framework Convention on Climate Change from 2010 to 2016, she actively coordinated climate change initiatives to jointly deliver the 2015 Paris Agreement. She will discuss the latest trends in climate action and net-zero policies on the second day of Forum (12 January).Discussion sessions on hot market topicsThe two-day Forum will include more than 40 discussion sessions, featuring heavyweight financial, government and business leaders to shed light on major topics, including global economic outlook, regional trade collaborations such as the Regional Comprehensive Economic Partnership Agreement (RCEP) and Guangdong-Hong Kong-Macao Greater Bay Area, asset and wealth management, environment, social and governance (ESG) and green finance, insurance and risk management, family office ecosystem, philanthropy and impact investing, financial inclusion, decentralised finance (DeFi), Web3 and Metaverse, monetary reforms and central bank digital currencies (CBDC) opportunities.In the main panel discussions, international financial and business leaders including Valerie Baudson, Chief Executive Officer of Amundi; Takeshi Kunibe, Chairman of the Board, Sumitomo Mitsui Financial Group and Sumitomo Mitsui Banking Corporation; Robert F. Smith, Founder, Chairman & CEO of Vista Equity Partners; Mark Tucker, Group Chairman of HSBC Holdings; Dr Jose Vinals, Group Chairman, Standard Chartered; Dr Ridha Wirakusumah, CEO of Indonesia Investment Authority and James Turner, Group Chief Financial Officer, Prudential will examine macroeconomic trends amid the epidemic recovery and external uncertainties, and key market opportunities.Tackling environmental challenges, energy and food crises has become top of the agenda on global level. Rapid development of Web3 and other financial technologies have also shaped the future of economy. In light of this, AFF will establish the Global Spectrum series, together with the Fireside Chat, to discuss various disruptive innovations and initiatives in society, covering venture capital and start-up ecosystem, transition to net-zero and ESG standard-setting, food security, health equity, metaverse and non-fungible token (NFT) and more. Speakers include Prof KC Chan, Senior Advisor, WeLab; Luanne Lim, Chief Executive, Hong Kong, HSBC; Benedicte Nolens, Head of the Hong Kong Centre, BIS Innovation Hub; Alfred Chuang, General Partner, Race Capital; Andrew Schwabecher, CEO & Representative Director, Japan Computer Vision Corp. and Adam Litle, Chief Executive Officer, Sound Agriculture. The Dialogues for Tomorrow series will also invite forward-looking industry leaders, including Sebastian Fahey, EVP, Managing Director, EMEA and Executive Lead, Metaverse, Sotheby's; Jeremy Coller, CIO, Managing Partner and Founder of Coller Capital and Charles Li, Founder and Chairman of Micro Connect.AFF Deal Flow in hybrid mode with extended periodIn addition to gathering global financial and business leaders to share insights, the HKTDC and the Hong Kong Venture Capital and Private Equity Association will again co-organise the AFF Deal Flow Matchmaking Session. The first two days of the matchmaking meeting (11 and 12 January) will allow participants to meet at the physical Forum venue, and continue online till 17 January with a digital extension, offering investors and project owners prolonged period to connect and explore collaboration opportunities. The matchmaking projects will cover industries ranging from deep technology, digital technology and media, medical technology, education and infrastructure to real-estate services. A function for identifying ESG-integrated projects debuted last year has also been enhanced to facilitate business matching.Nearly 100 exhibitors showcase new technologies and investment opportunitiesThe AFF will also house nearly 100 local and overseas exhibitors, international financial institutions, technology companies, start-ups and investment promotion agencies and sponsors including PwC, Standard Chartered Bank, Bank of China, HSBC, UBS, China International Capital Corporation, Huatai International, Hong Kong Exchanges and Clearing Limited and Cyberport to showcase leading financial technologies. Three highlighted zones, including Fintech Showcase, InnoVenture Salon and FintechHK Start-up Salon will allow on-site participants to experience technologies of tomorrow.Wide array of exclusive discounts and privileges for overseas delegatesAs the first large-scale business exchange event in 2023, the HKTDC has curated a variety of exclusive travel, food and hotel discounts and privileges in collaboration with Hong Kong Tourism Board, Klook, LKF Concepts and hotels to encourage AFF delegates from overseas to make the most out of their stay and experience the vitality of Hong Kong outside the Forum.Participants who register now can enjoy an early bird discount. More activity details, speaker line-up and media registration arrangements will be announced in early January.Website- Asian Financial Forum: https://www.asianfinancialforum.com/conference/aff/en- AFF Programme List: https://www.asianfinancialforum.com/conference/aff/en/info-programme- AFF Speaker List: https://www.asianfinancialforum.com/conference/aff/en/speaker- Media Room: http://mediaroom.hktdc.com- Photo download: https://bit.ly/3FklQrPMembers of the media interested in interviewing AFF 2023 speakers can send an email to tleung@yuantung.com.hk or ayiu@yuantung.com.hk on or before 5 January 2023.About HKTDC The Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on Twitter @hktdc and LinkedIn.Media enquiriesYuan Tung Financial Relations:Tiffany Leung, Tel: +852 3428 2361, Email: tleung@yuantung.com.hkAgnes Yiu, Tel: +852 3428 5690, Email: ayiu@yuantung.com.hkFung Wong, Tel: +852 3428 3122, Email: hfwong@yuantung.com.hkHKTDC's Communications & Public Affairs Department:Katy Wong, Tel: +852 2584 4524, Email: katy.ky.wong@hktdc.orgSnowy Chan, Tel: +852 2584 4525, Email: snowy.sn.chan@hktdc.orgSunny Ng, Tel: +852 2584 4357, Email: sunny.sl.ng@hktdc.org Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
SinoMab Awarded the “Most Valuable Pharmaceutical and Medical Company” in the Selection of the “7th Hong Kong Golden Stocks Awards” ACN Newswire

SinoMab Awarded the “Most Valuable Pharmaceutical and Medical Company” in the Selection of the “7th Hong Kong Golden Stocks Awards”

19 12 月, 2022
HONG KONG, Dec 19, 2022 - (ACN Newswire via SEAPRWire.com) - SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that the Company was awarded the "Most Valuable Pharmaceutical and Medical Company" at the "7th Hong Kong Golden Stocks Awards Ceremony" held in Hangzhou today.The Company Awarded the "Most Valuable Pharmaceutical and Medical Company"The "Most Valuable Pharmaceutical and Medical Company" award aims to recognize Hong Kong-listed pharmaceutical and medical companies that have a healthy corporate governance structure, prominent industry status, sound governance structure, good main business, and the ability to provide investors with sustainable and stable values. SinoMab was awarded the "Most Valuable Pharmaceutical and Medical Company", highlighting the attention and recognition of the industry and investors on the Company's value and innovation capabilities, which is a great encouragement and even a spur to SinoMab.SinoMab is the first Hong Kong-based listed biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics, primarily monoclonal antibody ("mAb")-based biologics, for the treatment of immunological diseases. With R&D headquarter in Hong Kong and production base in China, the Company strives to become a leading global biopharmaceutical company for the development of novel drugs to fulfil unmet medical needs through its Hong Kong-based innovative R&D, and PRC-based manufacturing capabilities. Currently, various candidate products for all-field indications of autoimmune diseases in SinoMab's layout have started clinical trials successively and are progressing steadily. In particular, SM03 (Suciraslimab), the Company's flagship product, is a potential global first-in target mAb for the treatment of rheumatoid arthritis ("RA") and other immunological diseases such as Alzheimer's disease ("AD"), systemic lupus erythematosus ("SLE"), Sjogren's syndrome ("SS") as well as non-Hodgkin's lymphoma ("NHL"). The Phase III clinical trial of SM03 for treatment of RA completed its enrollment on 31 December 2021, and is expected to complete the last subject visit (FV) in December 2022, read out clinical data in the first quarter of 2023 and submit a New Drug Application ("NDA") to the National Medical Products Administration (the "NMPA") of the People's Republic of China ("PRC") for commercialization in the second half of 2023 at the earliest.Under normal operation of the human immune system, the B-cell receptor (BCR) pathway would be activated and create strong signals in response to foreign ("non-self") antigens and trigger a series of B-cell immune responses. To differentiate from our "self" antigens, our body would recruit molecules, like SHP-1, to inhibit or reduce BCR-induced signaling, thereby suppressing B-cell immune responses. SM03 can be used to recruit such immunosuppressive molecules as SHP-1 by conversion of cis-binding CD22 to trans-binding CD22, forming a stable CD22 trans-binding structure, thereby restoring the tolerance of B cells to our "self" antigens and inhibiting a series of immune responses of B cells to attack our "self" antigens, thus suppressing relevant immune responses.Most of the mechanisms of action of existing RA therapies will result in the depletion or death of B cells, which can have a series of side effects on the human autoimmune system. In contrast, SM03 suppresses the autoimmune response by regulating the function of B cells and does not damage the B-cells and does not affect the normal function of B-cells in the immune system. Data from the Phase II clinical trial showed that SM03 has a comparable response rate and a significant safety advantage over competing products currently available on the market.In addition, SN1011, a key product of the Company, has obtained four IND approvals from the NMPA for the treatment of SLE, pemphigus ("PV"), multiple sclerosis ("MS"), neuromyelitis optica spectrum disorder ("NMOSD") respectively. At the same time, the Company is planning an IND submission for MS in the U.S. SM17 (a humanized anti-IL-7RB monoclonal antibody for injection), another key product of the Company, its first healthy subject had been successfully dosed in a Phase I First-in-Human (FIH) clinical trial in the U.S. in June this year and the subjects are currently in normal condition.Previously, SinoMab appointed Mr. Shanchun WANG as the President (China) of the Company, mainly responsible for the China operation. Mr. Wang has rich experience in the pharmaceutical industry for more than 30 years, served as the executive director of Sino Biopharmaceutical Limited and the president of Chia Tai - Tianqing Pharmaceutical Group Co. Ltd., and is a specialist that granted the special government allowances of the State Council and awarded as a national model worker. SinoMab's dedication to the field of autoimmune diseases and its vision of growing into a global leader in novel treatments of immunological diseases is highly consistent with the development model of Mr. Wang's service enterprises in the past. As one of the leaders in the biopharmaceuticals enterprise in China with rich experience and practical achievements in corporate strategic management, organizational management, innovation research and development and product commercialization, Mr. Wang's engagement as the President (China) of the Company will help expediting the Company's development from a global drug research and development enterprise to a biopharmaceutical company bearing commercialization capabilities and international perspective.Dr. Shui On LEUNG, Chairman, Executive Director and Chief Executive Officer of SinoMab said that: "The Company is deeply honored to be awarded the "Most Valuable Pharmaceutical and Medical Company" in the selection of the "7th Hong Kong Golden Stocks Awards", which reflects the capital market's recognition of the Company's value, innovation capabilities and growth potential, and is a great encouragement to the Company. In the future, the Company will, in line with its original purposes, endeavor to discover and develop innovative drug targets, explore therapies for immune diseases, accelerate R&D and clinical trials of various products, and at the same time further expand the product pipeline and potential indications, accelerate the realization of product commercialization, strive to bring benefits to patients and create values for shareholders and investors. With the imminent completion of the Phase III clinical trial of its flagship product SM03, the Company is poised for a new leap of increase in value."About the Selection of the "7th Hong Kong Golden Stocks Awards"The selection of the "7th Hong Kong Golden Stocks Awards" was jointly organized by Zhitongcaijing.com, a leading Hong Kong and US stock information platform in China, with RoyalFlush Finance and China Galaxy Securities. This selection was rigorous and attracted over 1,000 entries from Hong Kong-listed companies, covering traditional industries such as petrochemicals, finance, and automobiles, as well as emerging industries such as chips, Internet, and medical and pharmaceuticals, which are leading the transformation of China's economy.About SinoMab BioScience LimitedSinoMab BioScience Limited (stock code: 3681.HK) is dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases. The Company's flagship product SM03 is a potential global first-in-target mAb against CD22 for the treatment of rheumatoid arthritis (RA) and is currently in Phase III clinical trial for rheumatoid arthritis in China, which has been recognized as one of the significant special projects of Significant New Drugs Development of the Twelfth Five-Year Plan Period and the Thirteenth Five-Year Plan Period. In addition, the Company possesses other potential first-in-target and first-in-class drug candidates, some of which are already in clinical stage, with their indications covering rheumatoid arthritis (RA), Alzheimer's disease, systemic lupus erythematosus (SLE), pemphigus (PV), multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), non-Hodgkin's lymphoma (NHL), asthma, and other diseases with major unmet clinical needs. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
中国抗体荣获“第七届金港股”评选中“最具价值医药及医疗公司”奖项 ACN Newswire

中国抗体荣获“第七届金港股”评选中“最具价值医药及医疗公司”奖项

19 12 月, 2022
HONG KONG, Dec 19, 2022 - (亚太商讯 via SEAPRWire.com) - 中国抗体制药有限公司（“中国抗体”或“公司”，连同其附属公司，统称“集团”；股份代号：3681.HK），专注研究、开发、制造及商业化免疫性疾病创新疗法的香港生物制药公司，欣然宣布，今天在杭州举办的“第七届金港股年度颁奖盛典”上荣获“最具价值医药及医疗公司”奖项。公司荣获“最具价值医药及医疗公司”奖项“最具价值医药及医疗公司”奖项旨在表彰公司行业地位显著、治理结构健全、主营业务良好，能为投资者提供持续、稳定价值回报的医药及医疗类港股上市公司。此次中国抗体获得“最具价值医药及医疗公司”奖项，突显行业和投资者对公司价值和创新能力的关注与认可，对中国抗体是极大的鼓励与鞭策。中国抗体是专门研究丶开发丶生产及商业化免疫性疾病疗法的第一家以香港为基地的生物制药上市公司，主要研制以单克隆抗体为基础的生物制剂。公司的研发总部位于香港、生产基地位于中国，凭借在香港的创新研发能力及在中国的生产制造能力，致力成为开发创新药物以填补未满足医疗需求的全球领先生物制药公司。目前，中国抗体布局自身免疫疾病全领域适应症的多款候选产品已陆续开展临床试验，并稳步推进。其中，公司的旗舰产品SM03（Suciraslimab）是全球同类靶点中首个潜在用于治疗类风湿关节炎（“RA”）及其他免疫性疾病（如阿兹海默症（“AD”）、系统性红斑狼疮（“SLE”）丶干燥综合症（“SS”）以及非霍奇金淋巴瘤（“NHL”））的单抗药物。SM03治疗RA的III期临床试验已于二零二一年十二月三十一日完成招募，预计于二零二二年十二月完成最后一例受试者访视（FV），于二零二三年第一季度临床资料读出，最早于二零二三年下半年中国国家药品监督管理局 (“国家药监局”)提交新药上市申请（“NDA”）。在人体免疫系统正常运行的前提下，当外来抗原入侵时，B细胞受体通路会被激活，向B细胞传递抗原刺激信号，引发一系列B细胞免疫反应。而在面对自身抗原时，正常的机体会招募免疫抑制分子如SHP-1，通过阻止或是减弱B细胞受体通路向B细胞传递抗原刺激信号来抑制B细胞相关免疫反应。SM03可以通过转变CD22的结合方式，从顺式结合转变为反式结合，形成稳定的CD22反式结合结构，实现招募这类免疫抑制分子如SHP-1的功能，进而恢复B细胞对自身抗原的容忍度，抑制B细胞发生一系列相关免疫反应攻击自身机体，进而达到抑制相关免疫反应的作用。目前现有RA疗法的作用机理大多会在一定程度上引发B细胞的耗竭或是衰亡，对人体自身免疫系统产生一定的副作用，但SM03是通过调节B细胞的功能来抑制自身相关免疫级联反应的发生，并未损伤到B细胞本身，不影响B细胞在免疫系统中发挥作用。SM03在II期临床试验中的数据显示其应答率与市场上的现有竞品相当，在安全性方面有显著的优势。另外，公司主要产品SN1011现时已取得四项由国家药监局获批的不同适应症的新药临床研究申请（“IND”），分别针对系统性红斑狼疮（“SLE”）、天疱疮（“PV”）、多发性硬化症（“MS”）及视神经脊髓炎谱系疾病（“NMOSD”）。公司亦正准备在美国提交SN1011针对MS的新药研究申请。公司另一主要产品SM17（注射用人源化抗IL-17RB单克隆抗体）亦于今年六月在美国完成其I期临床试验之首例健康受试者给药，目前受试者情况正常。此前，中国抗体委任王善春先生为中国区总裁，主要负责中国区业务。王善春先生在医药行业有逾三十年的丰富经验，曾任中国生物制药有限公司执行董事、正大天晴药业集团股份有限公司总裁，为享受国务院特殊津贴专家，被授予“全国劳动模范”称号。中国抗体专注深耕自身免疫疾病领域，“成为免疫性疾病创新疗法的全球领先者”的愿景与王善春先生过往服务企业的发展模式非常吻合。王善春先生作为中国生物制药企业的领导者之一，在企业战略管理、组织管理、创新研发和产品商业化等方面有着丰富的经验和实践成果，加入中国抗体担任中国区总裁，将帮助公司加快实现从全球药品研发型企业向具有国际视野的商业化能力的生物制药公司迈进。中国抗体主席、执行董事兼首席执行官梁瑞安博士表示: “公司在‘第七届金港股’评选中获颁‘最具价值医药及医疗公司’奖项深感荣幸，反映了资本市场对公司的价值丶创新能力和发展潜力的肯定，对公司是极大的鼓励。未来，公司将不忘初衷，致力发现及开发创新型药物靶点，开拓针对免疫疾病的疗法，加快推进各项产品的研发工作和临床试验，同时进一步扩大产品管线及潜在适应症，加快实现产品商业化目标，为患者谋求福祉、为股东创造价值。随着公司旗舰产品SM03 III期临床试验的即将完成，公司的价值将会迎来新的飞跃。”关于“第七届金港股”评选“第七届金港股”由国内领先的港美股信息平台智通财经与同花顺财经丶中国银河证券联合主办。是次评选经过严格筛选，吸引了超过1000家港股上市公司参会报名，涵盖石化、金融、汽车等传统产业，又囊括了芯片、互联网、医疗医药等引领中国经济转型的新兴产业。关于中国抗体制药有限公司中国抗体制药有限公司专注于研究、发展、制造及商业化免疫性疾病疗法。公司注重科技研发，其旗舰产品SM03为全球首项用以治疗类风湿关节炎的潜在抗CD22单抗，已在中国进入类风湿关节炎三期临床试验，并被列为国家十三五重大新药创制专项重大项目。此外还有多个同类靶点首创（First-in-target）及同类首创（First-in-class）在研药物，部分已处于临床阶段，适应症覆盖类风湿性关节炎、阿兹海默症、系统性红斑狼疮、天疱疮、多发性硬化症、视神经脊髓炎谱系疾病、非霍奇金氏淋巴瘤、哮喘等具有重大未满足临床需求的疾病。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
Nissin Foods (Hong Kong) Charity Fund and The Education University of Hong Kong Launch Scholarship for Elite Athletes ACN Newswire

Nissin Foods (Hong Kong) Charity Fund and The Education University of Hong Kong Launch Scholarship for Elite Athletes

19 12 月, 2022
HONG KONG, Dec 19, 2022 - (ACN Newswire via SEAPRWire.com) - Nissin Foods Company Limited ("Nissin Foods", and together with its subsidiaries, the "Group"; Stock code: 1475) has announced the launch of the Nissin Foods Scholarship for Elite Athletes by Nissin Foods (Hong Kong) Charity Fund ("Charity Fund") and The Education University of Hong Kong ("EdUHK").Mr. Kiyotaka ANDO, Chairman of Nissin Foods (Hong Kong) Charity Fund (middle right), and Professor Stephen CHEUNG Yan Leung, President of EdUHK (middle left), announced the launch of the Nissin Foods Scholarship for Elite Athletes. The four scholarship recipients for the 2022-2023 academic year are - Mr. Dickson TAM Joe Dick (first from left); Mr. WONG Hong Ching (second from left); Mr. CHOI Kwan Lok (first from right) and Ms. FU Chi Yan (second from right).The Scholarship is intended to encourage elite athletes who are on the Bachelor of Health Education (Honors) program or the Postgraduate Diploma in Education program at EdUHK to continuously pursue excellence in their athletic performance and their studies to become educators of health in the future. The four scholarship recipients for the 2022-2023 academic year are: Mr. CHOI Kwan Lok (cycling, retired); Ms. FU Chi Yan (badminton); Mr. Dickson TAM Joe Dick (triathlon, retired); and Mr. WONG Hong Ching (shuttlecock).Mr. Kiyotaka ANDO, Chairman of Nissin Foods (Hong Kong) Charity Fund, said, "As a leading food manufacturer, we are not only committed to exploring food-related possibilities and creating fabulous tastes, but also nurturing talents for the food industry and the society. This is why we launched the Scholarship for Elite Athletes. We believe that by cultivating a healthy lifestyle among young people through food and sports, a new crop of elite athletes will emerge to carry on the Team Nissin spirit - passing it on from one generation to the next." Professor Stephen CHEUNG Yan Leung, President of EdUHK, expressed his sincere gratitude to the Charity Fund for their generous donation, and added, "The establishment of the scholarship enables current and retired athletes to diversify their career development. We also hope the perseverance and indomitable spirit these student-athletes demonstrate will set a good example for other students."Ms. ZHANG Ling, Sports Ambassador of Nissin Foods and former Hong Kong No. 1 tennis player, said, "I am glad to see our society showing greater care and appreciation towards athletes and supporting them in different ways. As a professional tennis player, I understand very well the many challenges that elite athletes face and what they need. I'm proud to be part of a team responsible for creating a better learning environment for potential teachers, which will ultimately help various beneficiaries, including the children in need. Through our collaborative efforts, we will play an active role in cultivating future leaders who will have a positive impact on Hong Kong, making it an even better place." About Nissin Foods (Hong Kong) Charity Fund The Nissin Foods (Hong Kong) Charity Fund ("Charity Fund") was set up in September 2020 by way of a trust deed by Nissin Foods Company Limited (Stock code: 1475). The Charity Fund obtained the tax exemption status for charitable institutions accorded by section 88 of the Inland Revenue Ordinance (Cap. 112) in September 2021. The objectives of the Charity Fund are: a) to advance education, teaching, learning, arts, science and academic research; b) to make provision for people in need; and c) to carry out works of a charitable nature that are beneficial to the Hong Kong community. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
天韵国际成功研发新品水果粒维生素运动饮料及水果酵素运动饮料 加速布局功能饮料大市场 ACN Newswire

天韵国际成功研发新品水果粒维生素运动饮料及水果酵素运动饮料 加速布局功能饮料大市场

19 12 月, 2022
HONG KONG, Dec 19, 2022 - (亚太商讯 via SEAPRWire.com) - 中国领先的品牌加工水果产品销售商及制造商天韵国际控股有限公司 (「天韵国际」或「公司」及其附属公司统称「集团」) (股份代号 : 6836.HK) 欣然宣布，继集团自家品牌成功推出「享派Shiok Party」维生素运动饮料及「妖果季」大果粒饮料后，即将隆重推出集团最新研发的新品水果粒维生素运动饮料及水果酵素运动饮料。目前，该系列新品饮料已经完成研发，正进入生产和销售工作的准备阶段，预计将于2023年初推出市场，加速布局市场需求日益上升的功能饮料大市场。新品水果粒维生素运动饮料效果图(仅供参考)新品水果酵素运动饮料效果图(仅供参考)即将登场的水果粒维生素运动饮料系列，是将桃子、苹果等水果加工成水果粒融入饮料之中。该产品不仅可以提升人体的能量代谢，更有帮助抗疲劳、缓解身体困乏的作用。此外，在此特色产品中添加的水果粒，给消费者提供良好的咀嚼感和丰富的水果风味，适应多种场景，包括日常生活、运动健身、学习、娱乐、出外游玩，是激发潜能、提高效率的必然之选。同时，全新研发的水果酵素运动饮料系列，选用桃子、苹果等作为原材料，产品主打提供符合大众日常生活所需的酵素理念，具备多种不同的健康功效，是配合大众健康意识日益增强所推出的功能饮料。据悉，该系列产品属于《山东省新旧动能转换重大工程实施规划》「十强」产业中的「医养健康–健康食品加工」产业，符合国家和山东省产业的发展方向。集团主席兼行政总裁杨自远先生表示：「随着人们健康意识日益增强，消费者的消费观念及饮食喜好和习惯的改变，近年来功能饮料市场增长迅速，饮用场景不断扩大，为市场提供了前所未有的发展机遇。在实施《健康中国2030》重大战略的社会背景下，集团善用自身的行业经验和优势，研发出不同于现有市场同类产品的两种新型特色饮料。这不仅符合集团一贯丰富产品类别及品牌组合的战略方针外，另一方面亦满足客户需求以及消费者的全新口味。随着我们产品日益多样化，预计集团在特色饮料细分市场尤其是功能饮料领域的竞争力将会进一步提升。」杨主席续道：「集团新研发的特色饮料系列新品，以现代营养学和运动医学理论为依据，提供营养补充和维持身体健康包括提高免疫力、减肥、抗衰老、运动增肌、肠道调理等各种功效，相信产品正式推出市场后，将会引起积极反应。而随着特色饮料及加工水果产品的市场需求持续上升，集团将继续积极研发创新，持续为客户及消费者带来更多不同种类的特色饮料及休闲食品，满足市场所需，积极带动行业践行高质量发展，以回馈社会和消费者对我们的支持和信任。」 关于天韵国际控股有限公司(股份代号﹕6836.HK)天韵国际控股有限公司（「本公司」集团「统称（及其附属公司）」主要从事(i)生产及销售包装于金属罐、塑料杯、玻璃瓶及铝箔袋的加工水果产品，(ii)生产及销售饮料产品及(iii)新鲜水果买卖。加工水果产品以自家品牌「缤果时代」、「天同时代」和「果小懒」及原厂委托制造代工销售的方式出售。饮料产品以自家品牌「享派 Shiok Party」及「妖果季」出售。集团致力为客户提供健康安全的产品，作为国内外资质认证最为齐全的食品企业之一，时刻紧贴严格的国际生产标准，并就生产设施、质量监控及管理获授BRC(A)、IFS食品（高级）、FDA、HALAL、SC、KOSHER、BSCI及ISO22000认证，集团同时通过多个英国及美国超市内部的食品生产标准审核。同在国内，集团作为「同线、同标、同质」工程出口食品企业，供应国内市场和供应国际市场的产品达到相同的质量水平。自2016年起，集团自家品牌的优质加工水果产品一直获得市场的高度认可，并获国家级机构颁授「中国罐头产品质量证明标志」的荣誉及资格。集团在2017年分别被国际知名财经杂志《福布斯》评选为福布斯中国百强潜力上市公司及荣获「2017年度临沂市市长质量奖」荣誉。集团全新自有研发的纯水果休闲食品在2018年也荣获国家级的「发明专利证书」。于2019年，集团荣获国家级的《高新技术企业证书》。于2020年，集团连续第四年入选中国品牌价值评价榜单。欲了解更多集团详情，请浏览集团网站 www.tianyuninternational.com Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
Guangxi University of Foreign Language signs Memorandum of Understanding with Hang Seng University of Hong Kong ACN Newswire

Guangxi University of Foreign Language signs Memorandum of Understanding with Hang Seng University of Hong Kong

16 12 月, 2022
HONG KONG, Dec 16, 2022 - (ACN Newswire via SEAPRWire.com) - Guangxi University of Foreign Languages ("GUFL") and The Hang Seng University of Hong Kong ("HSUHK") signed a Memorandum of Understanding ("MoU") on 30 November 2022. The MoU promotes a deeper cooperation between the two universities by integrating resources, academic strengths, research and other specialized academic fields. It also enhances the cultivation of top-notch multilingual talents with international perspectives that are needed to support the Greater Bay Area's future development. Additionally, it encourages graduates from the two universities to explore the tremendous market opportunities available within the ASEAN economies that are being fueled by the Belt and Road Initiative. Front row from left, Professor Gibert Fong (2nd), Professor Bradley R. Barnes (3rd), Ms. Wei Qian (4th), and Mr. Chow Ka Wo, Alex as well as other representatives took a group photo after the signing ceremony.Representatives who attended the online signing ceremony include Professor Gibert Fong, Dean from School of Translation & Foreign Languages of HSUHK, Professor Bradley R. Barnes, Dean from Business of School of HSUHK, Ms. Wei Qian, Executive Director, the chairlady of the Board and the chief executive officer of InnoEd Group Limited, Chairman and CEO, and Mr. Chow Ka Wo, Alex, Chief financial officer of InnoEd Group Limited. The MoU creates a unique collaborative arrangement that establishes exchange services between the two universities and enriches students learning experience. The student exchange program enables eligible students to enroll at the other's university in order to widen their academic exposure and enhance their international experience. Additionally, a faculty exchange program is being established to promote academic interaction and cooperation, as well as create a strong foundation to develop joint training programs, joint research programs, and share teaching curriculum. The two universities will promote academic cooperation and educational programs development by regular exchanges, mutual visits, academic interaction and cooperation between faculty and students. Futhermore, the universities will actively explore opportunities to cooperate in joint research projects, international conferences, seminars and other academic exchange activities to enhance their academic reputations, strengthen their education programs in related industries and promote mutual progress in teaching, research and other academic aspects.Expanding higher education's prospects through cooperation, cultivating talents with international perspectives GUFL's management stated that GUFL aims to cultivate talents with multiple language skills, practical business knowledge and international perspectives. GUFL is ideally positioned in Guangxi, a frontier and important window for exchanges and cooperation between China and the ASEAN countries. The university is using its geographical advantage to develop the necessary talent to support the development of the ASEAN region and Belt and Road Initiative. In contrast, HSUHK is based in Hong Kong, a renowned international city that plays an important role in the development of the Greater Bay Area. The university implements a unique "Liberal + Professional" education model that prioritizes teaching quality and students' all-round development to foster students realizing their full potential.Through the universities' exchange programs and cooperation, the Management believes that it will not only help expand cooperation between other universities in Mainland China and Hong Kong to develop similar academic exchange programs, joint research and other collaborations, but also promote students from the two places to gain a broader international perspective and contribute to the country's future development. The GUFL program will bolster students' knowledge of non-language majors while also developing their foreign language skills. This program embraces the school's educational philosophy of placing equal emphasis on language learning and professional education, while also enabling students to broaden their international perspective through attending HSUHK. Additionally, the cooperation provides an opportunity for HSUHK students to develop a second language, and learn about Southeast Asian culture. Essentially, the exchange program cultivates outstanding talents who can contribute to the deepening ASEAN economic cooperation and development. With unique teaching backgrounds and geographical advantages, the cooperation is expected to develop talents with international vision and promote the diversification and internationalization of the higher education industry in both Mainland China and Hong Kong.Pursing national policies to advance the Greater Bay Area developmentThe Central Committee of the Chinese Communist Party and the State Council issued its "Outline Development Plan for the Guangdong-Hong Kong-Macao Greater Bay Area", which calls for building an education and talent highland in the Greater Bay Area. The outline includes cooperation among schools and universities, encouraging joint development of advantageous disciplines, laboratories and research centers, supporting the construction of an international education demonstration zone in the Greater Bay area, encouraging Hong Kong and Macao youths to study in Mainland China schools, promoting cooperation in various aspects of vocational education in Guangdong, Hong Kong and Macao, expanding cooperation between the Mainland China, Hong Kong and Macao universities, and supporting exchanges and cooperation among various vocational education training bases."This cooperation closely follows the Greater Bay Area development plan and is in line with the Greater Bay Area's talent cultivation policy. Both institutions will further explore innovative ways to strengthen students' academic progress through exchange programs and interactions between teachers and students, so as to empower the future development of the Greater Bay Area." The Management continued. Providing Hong Kong's needed multilingual talent, deepening and expanding the market opportunities in ASEAN region and the Belt and Road Initiative As the international city of the Greater Bay Area, Hong Kong has many permanent residents from ASEAN countries. The open economic system and position as an international financial, trade and shipping centre creates strong demand for multilingual talents. GUFL, as the only private undergraduate university of foreign languages in Guangxi, specializes in providing top quality language programs focusing on Southeast Asian languages. The university embraces the mission of "Established in Guangxi, Oriented towards China, Radiate to Southeast Asia" to meet the many evolving demands driven by local and regional socio-economic developments. The exchange programs and cooperation will not only help meet Hong Kong's demand for multilingual talents, but will also provide Hong Kong students with the opportunity to experience Guangxi and learn about Southeast Asia's diverse culture. This knowledge will be invaluable to developing career opportunities in the Asia Pacific region.The GUFL Management commented, "Signing the MoU with HSUHK opens up new prospects for the university and our students. The cooperation will enable us to cultivate more multilingual talents with an international perspective. Simultaneously, it enhances the relationship between two top universities, and further strengthens the communication between the Mainland China and Hong Kong in the field of higher education."Looking forward, Management expects to develop stronger professional and applied Southeast Asian language programs and cultivate more talents with a balanced emphasis on strengthening language skills and professional education, thereby promoting the integrated development of Guangxi and the ASEAN regions for building a strong highly educated society.About Guangxi University of Foreign LanguagesGuangxi University of Foreign Languages ("GUFL") is affiliated to the InnoEd Group Limited, who is the largest private foreign language higher education institution in China. GUFL is the largest private undergraduate education institution in Guangxi in terms of undergraduate enrolment in the 2020/2021 academic year, according to Frost & Sullivan. GUFL primarily offers bachelor's degree programmes and junior college diploma programmes. The curricula is designed with a distinct emphasis on the integration of language learning with professional education. It specializes in the education of Southeast Asian languages, including Thai, Vietnamese, Cambodian, Lao and Indonesian. Meanwhile, it offers 56 majors across six main academic disciplines, including literature, economics, management, education, arts and engineering.The two campuses of GUFL are situated in Nanning, Guangxi, the permanent site of the China-ASEAN Expo, and Fusui, Guangxi, National Nanning - ASEAN Economic Development Zone, being strategic locations in the development of free trade and economic cooperation between China and the ASEAN. GUFL has adopted the service-oriented positioning of "Established in Guangxi, Oriented towards the entire China, Radiate to the Southeast Asia" and has a mission to cultivate talent with niche language skills, practical knowledge and an international perspective to meet the evolving demands driven by local and regional socio-economic developments. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
广西外国语学院与香港恒生大学签署合作备忘录 ACN Newswire

广西外国语学院与香港恒生大学签署合作备忘录

16 12 月, 2022
HONG KONG, Dec 16, 2022 - (亚太商讯 via SEAPRWire.com) - 在粤港澳大湾区发展紧密合作规划下，高等教育界的跨地合作亦更进一步深化。广西外国语学院(「广西外院」)与香港恒生大学(「恒大」)于2022年11月30日签署了为期三年的合作备忘录。此次合作不但有助于推进双方在教学、研究及其他学术方面的深化协作、资源融合、优势互补，并加强培育及积累具有国际视野的多语种人才，赋能大湾区的未来发展，并助力两家高等学院的毕业生进一步把握东盟合作及「一带一路」倡议下所带来的巨大市场机遇。图示香港恒生大学翻译及外语学院院长方梓勋教授(前排左二)、香港恒生大学商学院院长李海东教授(前排左三)、新高迪集团执行董事、董事会主席兼首席执行官韦茜女士(前排左四)、新高迪集团首席财务官周家和先生(前排左五)及其他代表于签署仪式完毕后合照。据了解，出席是次合作备忘录在线签署仪式的代表有﹕香港恒生大学翻译及外语学院院长方梓勋教授、香港恒生大学商学院院长李海东教授 (Professor Bradley R. Barnes) 、新高迪集团执行董事、董事会主席兼首席执行官韦茜女士、以及新高迪集团首席财务官周家和先生等人。在此次合作备忘录的框架下，每所大学每年可派遣学生到另一所大学交换就读，同时鼓励两校之间交换教员，促进其教师之间的交流合作，为联合培育项目的发展、联合研究项目的制定、教材的交流和学生的访问奠定坚实的基础。双方将透过加强两校师生之间的交流、互访、联系与合作，促进学术合作和教育项目的发展；同时两校亦积极探索在联合研究项目、国际会议、研讨会及其他学术交流活动的合作机会，以提升两校作为相关行业优质服务提供商的形象，促进双方在教学、研究及其他学术方面的共同进步。拓展两地高等教育深化合作培育和积累具有国际视野的复合型人才广西外国语学院管理层表示：「广西外院以培养有专门外语语言技能、实用知识及国际视野人才为己任，强调『外语+专业』的结合。学校位于广西与东盟的战略性位置，毗邻东盟多个国家，可善用面向东盟的区位优势，对接『一带一路』建设人才需求。」香港恒生大学则立足香港，面向国际及大湾区，其采用独特的「博雅+专业」教育模式，以优质教学和学生的全方位发展为最优先目标。广西外院管理层相信，通过双方的持续交流与合作，不但有助于拓展内地高校与香港高校在学术交流、联合研究等领域的合作前景，更可促进两地学生获得更广阔的国际视野，为国家的未来发展作出更多贡献。建基于双方优势资源的互补，一方面有助于让广西外院的学生在外语学习的同时，加强非语言专业的学习与见闻，体现该校语言学习与专业教育并重的教育理念，亦令他们通过香港这个平台，开阔其国际视野。此次合作依托双方独特的教学背景以及地理位置，相信将有助于共同培育和积累具有国际视野的复合型人才，推进两地高等教育行业多元化及国际化。紧跟国家政策 赋能大湾区发展中共中央、国务院于2019年12月18日印发《粤港澳大湾区发展规划纲要》提出，要求推动教育合作发展，打造粤港澳大湾区教育和人才高地。其中包括开展合作办学、鼓励联合共建优势学科、实验室和研究中心、支持大湾区建设国际教育示范区、鼓励港澳青年到内地学校就读、推进粤港澳职业教育多方面的合作，创新内地与港澳合作办学方式，支持各类职业教育实训基地交流合作等。「是次合作紧跟大湾区发展规划，符合大湾区人才培育政策，双方院校通过加强师生之间的交流、互访与联系，深入探索学术方面的共同进步，赋能大湾区的未来发展。」管理层续称。满足香港的多语种人才需求 深化拓展东盟及「一带一路」的市场机遇香港作为大湾区内最具国际化的城市，来自于东盟国家的常住人口多达数十万，且其开放型的经济体系亦令当地需要更多多语种的人才，以巩固及加强其国际金融、贸易和航运中心的地位。广西外院专门从事东南亚语言的教育，作为广西唯一一所外语类民办本科高校，其采用「立足广西，面向全国，辐射东南亚」的服务面向定位，以满足当地及区域社会经济发展所推动的不断变化的需求。管理层认为：「广西外国语学院此次与香港恒生大学达成合作备忘录，令本校的发展迈向一个新台阶，有助于本校培育更多具有国际化视野的多语种人才，同时增进了两地高校之间的情谊，进一步加强了内地与香港两地在高等教育领域的交流。这亦有助于推动满足香港的多语种人才需求，也令香港学子有机会走进具多元东南亚文化的广西，有利于其未来在亚太区域内体现个人潜能、开创事业。」展望未来，管理层期望广西外院能发展更具专业化与应用性的东南亚语言教育，培养更多语言学习与专业教育并重的复合型人才，带动广西与东盟地区共同融合发展，为社会创造更大价值。 关于广西外国语学院广西外国语学院(「广西外院」)隶属中国最大的民办外语高等教育机构——新高迪集团有限公司。根据弗若斯特沙利文，按2020/2021学年本科招生规模计，广西外院为广西最大的民办本科教育机构。广西外院主要提供本科课程及专科课程，其课程设计特别强调语言学习与专业教育(即外语+专业)的结合。广西外院专门从事东南亚语言的教育，包括泰语、越南语、柬埔寨语、老挝语及印度尼西亚语。同时，广西外院现提供56个专业，涵盖六大学科，包括文学、经济学、管理学、教育学、艺术学和工学。广西外院的两个校区分别位于广西南宁及广西扶绥，其分别为中国—东盟博览会永久会址及中国—东盟南宁空港经济区，地处中国与东盟自由贸易及经济合作发展的战略要地，广西外院已采用「立足广西，面向全国，辐射东南亚」服务面向定位，以培养有专门外语语言技能、实用知识及国际视野人才为己任，以满足当地及区域社会经济发展所推动的不断变化的需求。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
泰国新国轩成立 国轩欲打造电池出口东盟基地 ACN Newswire

泰国新国轩成立 国轩欲打造电池出口东盟基地

16 12 月, 2022
HONG KONG, Dec 16, 2022 - (亚太商讯 via SEAPRWire.com) - 12月15日，国轩高科与泰国PTT集团旗下能源解决方案公司Nuovo Plus签订合作协议，双方合资成立泰国新国轩有限公司（暂定名，以下简称泰国新国轩），专注电池模组及Pack产品的设计、开发、制造、销售和出口，共同探索东盟新能源市场，致力于打造电池出口东盟基地。泰国PTT集团是泰国最大的国家控股能源和石油化工公司，此次合作将推进泰国全面电气化进程，助力泰国实现2065年净零排放的承诺。15日上午，双方以视频的方式完成了此次协议的签署。根据协议约定，国轩高科旗下国轩新加坡公司与泰国PTT集团旗下Nuovo Plus有限公司达成战略合作，拟在泰国东部经济走廊地区合资建立泰国新国轩能源解决方案有限公司(NV Gotion Co., Ltd.，简称“NV Gotion”、“泰国新国轩”)。合资公司的业务包括电池模组和电池Pack的设计、开发、验证和制造，以及电池管理系统，产品适用于各类车用及储能系统。根据规划，泰国新国轩计划于泰国东部经济走廊地区建设锂离子动力电池的Pack生产线，预计到2023年第四季度，一期产线将投产并向市场提供高质量的电池产品。泰国新国轩在泰国实现电池本地化生产制造与市场开拓的同时，将积极探索东盟新能源市场，致力于打造电池出口东盟基地。泰国PTT集团是泰国最大的国家控股能源和石油化工公司，世界500强企业，旗下Nuovo Plus是一家致力于能源解决方案的公司。泰国PTT集团首席新业务和基础设施官兼 Nuovo Plus 董事长布兰宁·拉塔纳斯巴特博士在致辞中表示：Nuovo Plus的使命是根据PTT公司“用未来能源为生活提供动力”的愿景来投资电池业务领域，推动全社会使用可再生能源。泰国新国轩在开展电池业务、加强可再生能源生产和支持电动汽车行业供应链发挥着重要的作用。合资公司的成立，将有助于提高泰国使用可持续能源的水平，有助于支持PTT集团到2050年实现净零排放和泰国到2065年实现净零排放的目标。通过此次合作，PTT集团与国轩高科发挥各自优势，发展可持续的供应链、企业、产品和营销，提高产品的成本优势和竞争力，提供专业技术支持进行研究和开发，并为客户提供一站式服务。国轩高科董事长李缜在致辞中表达了此次合资的重要意义及对未来的期许，他表示：合作共赢，是合资公司设立的基础，相信本次合作将助力国轩高科全球布局，助力PTT集团加速新能源发展，实现共赢，为双方后续更多合作打下坚实基础；产品为王，是合资公司成功的关键，希望双方发挥各自优势，强强联合、优势互补，共同推进产品技术进步，实现性能提升，服务完善；推广应用，是合资公司发展的灵魂，合资公司将响应泰国政府发展绿色经济号召，服务泰国汽车电动化，助推泰国汽车产业国际化进程。国轩高科与PTT集团携手，以合资公司为平台，用一流的技术、一流的产品、一流的管理，让搭载泰国新国轩电池的电动车，享誉东南亚，并走向国际。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
HKTDC Export Index 4Q22: Hong Kong exports expected to grow 5% in 2023 ACN Newswire

HKTDC Export Index 4Q22: Hong Kong exports expected to grow 5% in 2023

15 12 月, 2022
HONG KONG, Dec 15, 2022 - (ACN Newswire via SEAPRWire.com) - The Hong Kong Trade Development Council (HKTDC) projects that Hong Kong's exports will grow 5% next year - a recovery from the 6% decline this year. HKTDC Director of Research Irina Fan said: "Hong Kong's exports will gradually regain growth momentum amid the receding pandemic, easing of COVID-19 restrictions and resumption of cross-border land transportation."HKTDC Director of Research Irina Fan (R) and Assistant Principal Economist (Greater China) Alice Tsang announced the HKTDC Export Index for the fourth quarter of 2022 and export forecast for 2023 at a press conference today (15 December)HKTDC Director of Research Irina FanHKTDC Assistant Principal Economist (Greater China) Alice TsangThe latest HKTDC Export Index survey shows that significantly more exporters indicated businesses were no longer suffering from pandemic-related problems (up 10.6 percentage points from the previous quarter to 32.7%), with progress made towards resolving the challenge of high transportation costs and logistics bottlenecks.Yet, more respondents said buyers haggled over prices (25.7%, up 9.3 percentage points) and reduced order sizes (40.1%, up 5.0 percentage points). Most respondents said they expected sales next year to decrease (49.4%) or remain on a par with sales this year (28.3%). "Lingering geopolitics, coupled with the risk of global stagflation, has dampened consumer sentiment and business confidence," Ms Fan explained.Recessions risksThe risks of an economic slowdown or recession in major markets (36.2%) and difficulties in cross-border travel (21.1%) have become exporters' key concerns. In response, most said they would develop new products (50.0%), stabilise cash flow (34.6%) and cut costs (30.5%) in the coming year. Other business strategies to be adopted included lowering minimum order quantities, increasing the use of e-commerce for sales and purchases as well as enhancing marketing, promotional or business matching activities."High inflation and high interest rates will weaken purchasing power and consumers' desire in the European and American markets. Meanwhile, the Association of Southeast Asian Nations (ASEAN) has become the bright spot for the city's exports. Local exporters should also pay more attention to the opportunities in the Mainland China market. Product-wise, toys and timepieces related to smart and intellectual property (IP) will have higher chance," Ms Fan said.Sentiment edges downThe HKTDC interviewed some 500 Hong Kong exporters in mid-November for the survey to gauge business confidence about near-term export prospects. Respondents come from six major industries - clothing, electronics, jewellery, machinery, timepieces and toys. Readings above 50 indicate a positive sentiment, while below 50 is negative.The HKTDC Export Index dropped 3.1 points from the previous quarter to 29.7. "The uncertainties led by slowing global demand has affected exporters' sentiments," said HKTDC Assistant Principal Economist (Greater China) Alice Tsang.Machinery, watches outperformMs Tsang added that machinery (38.3, up 3.4 points) was the most upbeat sector, followed by timepieces (36.8, up 3.0 points), while jewellery recorded a sharp fall of 13.4 points to 30.8. Other sectors such as toys (28.9, down 8.1 points) and fashion (23.8, down 7.4 points), also dropped significantly.It is worth nothing that all major markets recorded declines. Exporters have more confidence in Asian countries, with Japan topping the table at 47.2, followed by Mainland China (44.4) and the ASEAN bloc (43.5). They, however, remained less optimistic about the EU (40.4) and the US (40.2) markets, as persistent inflationary pressures and the likelihood of recession were set to hamper demand.Growth in AsiaIn the first 10 months of 2022, Hong Kong's total exports fell 4.4% over the same period last year. This was mainly due to pandemic disruption on cross-border trade flows between Mainland China and Hong Kong. Meanwhile, the city's exports to key major Asian markets saw double-digit growth, as the intra-regional supply chain expanded. For instance, Hong Kong's exports to the ASEAN bloc increased 12.6% year-on-year, while they surged 15.0% and 13.5% to Taiwan and Korea, respectively.However, Hong Kong's exports to the US showed no growth and shipments to the EU fell 2.9% during the same period, as aggressive central bank monetary tightening, high energy and food inflation as well as the lingering Russia-Ukraine conflict dampened consumer and business sentiment.New products, new opportunitiesLooking ahead, it is expected that toys exports will benefit from new 3D live-action games, and other peripheral products derived from film, TV and video games. Household electrical appliance exports will also pick up next year, as many restaurants, hotels and offices resume normal operations.New products, such as robot vacuum cleaners and sound-activated light switches, also appeal to consumers. Moreover, smartwatches with more advanced health and wellness functions, such as electrocardiogram (ECG) sensor and blood oxygen readouts are becoming more popular.To view our press releases in Chinese, please visit http://mediaroom.hktdc.com/tcReferences- HKTDC Research website: http://research.hktdc.com/ - HKTDC Export Index 4Q22: Local Exporter Confidence Falters in Face of Global Economic Slowdown https://bit.ly/3FNwCIz- Covid Legacy and Global Economic Downturn Impact Hong Kong's 2023 Export Outlook https://bit.ly/3FOh7QH- Photo download: https://bit.ly/3FOi7nIAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on Twitter @hktdc and LinkedIn.Media enquiriesPlease contact the HKTDC's Communication and Public Affairs Department:Beatrice Lam, Tel: +852 2584 4049, Email: beatrice.hy.lam@hktdc.org Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Global ESG Monitor（GEM）发布恒指成分股ESG透明度报告和评分 安踏体育、恒生银行、腾讯控股并列三甲 ACN Newswire

Global ESG Monitor（GEM）发布恒指成分股ESG透明度报告和评分 安踏体育、恒生银行、腾讯控股并列三甲

15 12 月, 2022
HONG KONG, Dec 15, 2022 - (亚太商讯 via SEAPRWire.com) - 恒生指数成分股中的企业在其ESG报告质量方面排于全球中等水平。这是Global ESG Monitor（GEM）2022年香港区域报告最新所得出的研究。GEM最新研究发现，作为恒生指数成分股的港股上市公司在非财务报告的透明度方面平均得分为57分（以最高分100分计），此意味着恒生指数成分股在此方面的排名处于同样被GEM调研的欧洲、北美、亚洲和澳洲的10大股票市场多个国际指数当中中档偏下的位置，排名仅仅高于标准普尔亚洲（56分）和澳洲ASX50（53分）的水平。GEM香港区域报告指出，在恒生指数当中，名列前茅的三家公司分别为，安踏体育(02020.HK)、恒生银行(00011.HK)和腾讯控股(00700.HK)，三者得分均为77分，并列成以ESG透明度而言，是次调研的蓝筹之冠。金沙中国(01928.HK)及汇控(00005.HK)则分别以75分及74分，位列蓝筹第四及第五位。其他列于首十位的上市公司包括:联想集团(00992.HK)、电能实业(00006.HK)、恒基地产(00012.HK)、中国移动(00941.HK)及恒隆地产(00101.HK)。上述报告提及，在恒生指数当中，较多公司（97%）愿意将其非财务报告建基于标准的国际框架上，不过，与全球比较而言，恒指成分股公司往往会较专注于平均6.7个参考框架和标准。而在所考察的10个指标当中，亦可见其他指标在报告长度上较为简洁。「当你浏览恒生的数据时，你会发现这种专注并不一定会成为一种优势。」GEM联合创始人兼研究和数据科学主管Ariane Hofstetter评论道：「不少情况变成，报告沦为欠缺重要细节，而这些细节本身能够令整体数据具有更好的可理解性、可靠性及可比性。」报告指出，如公司规模、员工数以及产品和服务组合等背景信息在非财务报告中相对完善。81%所调研公司亦有描述其经营的环境参数。不过，恒指成分股相关公司较少涉及其社会经济或政治状态（分别为75%和54%）。而仅得32%报告了其价值链。GEM联合创始人Michael Diegelmann认为：「事实上，企业实践可持续性，也需要整个供应链的紧密合作。恒指相关的公司在这方面，仍在缺乏能够对信息进行分类的信息。虽然83%的报告包含对供应链的描述，但同样缺乏与供应链相关的细节来评估其相关风险。例如，略低于三分之一的公司提供了与其业务相关的供货商类型信息，仅不足一半的公司说明了供应链上所估算的供货商的数量。」GEM香港区域报告指出，在社会议题方面，员工和人权的话题并不是恒指相关公司的报告当中，出现得最多的一个。例如，82%的公司没有说明歧视和骚扰的具体事件发生的程度。相比之下，相关报告在健康和安全问题上展示出更大的透明度，89%的公司表明其在此方面的立场，尽管十间当中只有七间公司更具体地报告了「因工伤而死亡的人数和比率」，仅四分之一的公司提供了「造成严重后果的工伤人数和比率」的信息。GEM香港区域报告提及，至于治理方面，恒指相关公司的报告往往更多地关注结构，并较少关注监事会的运作。大约七成公司报告了其如何确保或促进监事会对财务和非财务议题及决策的集体认识。只有64%公司报告了监事会在评估环境及社会风险管理方面的作用，并在向监事会报告的重大关注议题上的分数特别低。仅得四分之一的公司在这方面提供了信息，只有4%公司具体说明了向监事会报告的关键需关注议题的总数。Michael Diegelmann认为：「许多ESG报告缺乏细节和透明度的原因之一是，有关报告是依据香港交易所的ESG报告准则去编制。有关准则的最低披露要求较低，故令部份报告未有深入披露，尤其是与全球报告所倡议的要求去比较的话。」GEM香港区域报告亦指出，在恒生指数相关公司中，同样值得留意的是，很少公司愿意将其非财务报告提交予审计师。仅得32%的发行人作出相应的审计委托。而在70%的案例中，并没有提供审计深度的信息，只得16%的报告披露是以「合理保证(reasonable assurance)」进行审计。GEM香港区域报告区域合作伙伴、达博思传讯顾问有限公司董事总经理陈铠瑶女士总结道:「恒指相关公司普遍会认为，其向可持续发展方向发展迈进的同时，必须有恰当的报告披露相配合。无可厚非，恒指相关公司仍需做大量的工作及努力，以确保其报告能够借着提升透明度来带动其企业在可持续发展上作出改变。」GEM 2022香港区域报告完整内容： https://globalesgmonitor.com/download-report-form/有关报告的更多评级准则和细项请浏览： https://lbs-comm.com/global-esg-monitor-2022-report-scorings-is-out-now-two-hong-kong-companies-were-ranked-top-ten/ 关于 Global ESG Monitor (GEM)Global ESG Monitor(GEM) 是一个致力于调查非财务报告透明度的研究项目，结合分析特定时间内之可审计定量及定性信息。本系统采用特意为监测透明度而开发的研究工具GEM Assay™ ，并根据不断变化的条件和发展，逐年因应改变作出调整。GEM Assay™所依据的透明度是基于全球报告倡议组织 (GRI) 的相关准则、ISO标准26000和Accountability and Transparency, 2010a.如有查询，请联络达博思传讯顾问有限公司www.lbs-comm.com陈铠瑶 (Joanne Chan) 电话：（852）3679 3671 电邮：jchan@lbs-comm.com Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
医思健康夺得投资者关系杂志大中华区医疗健康行业公司最高荣誉奖 ACN Newswire

医思健康夺得投资者关系杂志大中华区医疗健康行业公司最高荣誉奖

14 12 月, 2022
HONG KONG, Dec 14, 2022 - (亚太商讯 via SEAPRWire.com) - 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，《投资者关系杂志》举办之2022 年度大中华区奖项评选中，集团于医疗健康行业公司中夺得最高荣誉奖。《投资者关系杂志》向全球各地于投资者关系领域有卓越表现的企业颁发荣誉，以表彰其在投资者关系领域的表率作用，全球数百名分析师及投资者会投票予其认为能提供最佳投资者关系沟通的公司。医思健康此次夺得的医疗健康行业公司最高荣誉奖充分反映公司致力秉持投资者关系行业之最高标准，备受投资界认可。医思健康主席、执行董事兼行政总裁邓志辉先生表示：「集团非常荣幸能于《投资者关系杂志》举办之2022 年度大中华区奖项评选中，夺得医疗健康行业公司最高荣誉奖。此项荣誉展现了投资界伙伴对集团在投资者关系方面付出的努力的认可。展望未来，集团将持续致力于提升于医疗健康市场的领导地位，令优质医疗服务可负担，可触达，可持续。集团期待携手价值观相同的持份者不懈努力，实现公司乃至社区之长远福祉。」关于医思健康 香港最大非医院医疗服务供应商*医思健康以预防及精准医疗为业务核心，透过多元服务整合发展医疗人工智慧，配套高端品牌及优质客户服务，致力为客户提供最专业、安全、有效的医疗健康服务。集团为恒生综合指数成份股及MSCI香港小型股指数。集团目前直营的诊所／服务中心主要位于大湾区，提供一站式医疗及健康服务。服务涵盖面极广，旗下主要知名服务品牌包括连续多年荣膺全港第一的一站式医学美容解决方案DR REBORN、专业健发中心发森及多元化多维度的医学服务包括：健康管理中心香港仁和体检中心、疫苗中心香港安苗医疗中心、普通科门诊未来医生、全港最大一站式痛症管理平台纽约脊骨物理治疗中心、全方位牙科服务中心庇利积臣牙科医务所，EC DENTAL CARE及恒健牙科医务所、高端影像中心博思医学诊断中心、仁生肿瘤及癌症中心、内视镜及日间医疗中心仁辉专科中心、专科中心进汇医务中心，联汇专科，新医疗中心、儿科专科汇儿儿科医务中心、妇产科专科卓越医务中心及产前诊断中心、柏立医学化验所、眼科中心唯视眼科和医思兽医医院及影像中心。*根据弗若斯特沙利文公司按2020年及2021年收入计算进行的独立研究 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
EC Healthcare wins “Best in Healthcare Sector” at IR Magazine's Greater China Awards 2022 ACN Newswire

EC Healthcare wins “Best in Healthcare Sector” at IR Magazine's Greater China Awards 2022

14 12 月, 2022
HONG KONG, Dec 14, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, is pleased to announce the Group has garnered the "Best in Healthcare Sector" at IR Magazine's Greater China Awards 2022.IR Magazine has honored excellence in investor relations around the world with awards which recognize companies that are leading the way for the IR community. This award is determined by the input of hundreds of analysts and portfolio managers, who give their opinions on which companies provide them with the best IR service. Winning this award showcases the Group's commitment to upholding the highest standard of investor relations and carries the weight of recognition from the entire investment community.Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare said, "The Group is honored to receive the "Best in Healthcare Sector" from IR Magazine Awards - Greater China 2022. This prestige Award demonstrates the recognition of our Group's efforts to achieve excellences in corporate governance, investor relations, transparency, and communication channel building. Looking forward, we will continue to spare tremendous effort with the aim of further consolidating the leading position in the healthcare market and make premium medical service affordable, attenable and sustainable. The Group wishes to excel together with our much-valued stakeholders to maximize overall welfare of our company and the greater community."About EC Healthcare EC Healthcare is Hong Kong's largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group's high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism. The Group is a constituent stock of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, a professional hair care center HAIR FOREST, primary care clinics jointly established with health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, General outpatient clinic Tencent Doctorwork, the largest one-stop pain management centre in Hong Kong New York Medical Group, the comprehensive dental centres Bayley & Jackson Dental Surgeons, EC DENTAL CARE and Health and Care Dental Clinic, an advanced diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic PREMIER MEDICAL CENTRE, SPECIALISTS CENTRAL and NEW MEDICAL CENTER, a paediatric centre PRIME CARE, a gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, PathLab Medical Laboratories, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.*According to independent research conducted by Frost and Sullivan in terms of revenue in 2020 and 2021 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Eco Expo Asia opens today ACN Newswire

Eco Expo Asia opens today

14 12 月, 2022
HONG KONG, Dec 14, 2022 - (ACN Newswire via SEAPRWire.com) - The Eco Expo Asia 2022, jointly organised by the Hong Kong Trade Development Council (HKTDC) and Messe Frankfurt (HK) Ltd and co-organised by the Environment and Ecology Bureau of the Government of the Hong Kong Special Administrative Region (HKSAR), begins today at the Hong Kong Convention and Exhibition Centre (HKCEC). The four-day Expo runs until 17 December and adopts the brand-new EXHIBITION+ model, which allows exhibitors and buyers to extend interactions from the physical fair to the online platform "Click2Match" until 24 December. The last day of the event on 17 December is open to the public for free to encourage them to take part in green activities and practice green living.The Eco Expo Asia 2022, jointly organised by HKTDC and Messe Frankfurt (HK) Ltd, opens today.HKTDC Deputy Executive Director Sophia Chong, spoke at the Opening Ceremony today.Tse Chin-wan, Secretary for Environment & Ecology of the HKSAR Government visits the fairground with Sophia Chong, Deputy Executive Director of the HKTDC, and other VIP guests.Tse Chin-wan, Secretary for Environment and Ecology, HKSAR Government and Sophia Chong, Deputy Executive Director, HKTDC, officiated at the expo's opening ceremony this afternoon. In her remarks, Ms Chong said: "Themed under 'Green Innovations for Carbon Neutrality', this year's Expo attracted close to 250 exhibitors from nine countries and regions gathering the latest green products, technology and solutions under one roof. It provides a prominent business platform for different industries to capture green business opportunities and help push forward sustainable development globally".Eco Asia Conference brings together industry leaders to unveil new trends and insightsAs the key event of the Expo, this year's Eco Asia Conference will be held from today to 16 December. The conference brings together industry leaders from all over the world to share their insights on the four major issues of environmental protection. In the session 'Potential of Repair and Reuse in Achieving a Circular Business Model', Simon Ng, Chief Executive Officer of the Business Environment Council, was invited to deliver a welcome address, followed by a discussion among representatives of the Business Environment Council and industry leaders on how to integrate item repair and reuse in different business models to drive a circular economy in Hong Kong.For the session 'Government Session: Carbon Neutrality - Challenges and Opportunities Ahead', Zhou Guomei, Director General, Hong Kong and Macao Affairs Office, Ministry of Ecology and Environment; Lu Xiulu, Director-General, Department of Ecology and Environment of Guangdong Province; Tam Vai Man, Director of the Environmental Protection Bureau of Macao SAR Government and Li Shuisheng, Director, Ecology and Environment Bureau of Shenzhen Municipality were invited to present the policies and share the latest developments for achieving carbon neutrality in Mainland China and Macao SAR.Eco Asia Conference will focus on two main themes tomorrow, including 'Advancing Net Zero - Retrofit for Building Energy Efficiency' and 'Green & Sustainable Finance Session: Establishing Hong Kong as a Regional Carbon Trading Hub'. In the first session, representatives from the Hong Kong Green Building Council and Sino Estates Management Limited discuss how building energy-saving retrofit projects can help drive Hong Kong towards carbon neutrality. In the second session, the Hong Kong Exchanges and Clearing Limited (HKEX), Securities and Futures Commission and a number of industry leaders have been invited to talk about green and sustainable financial market momentum in Mainland China, Hong Kong and globally, with a focus on how to establish Hong Kong as a regional carbon trading market. On the third day (16 December), the much-anticipated '3rd Hydrogen Economy Forum' has invited a number of experts to talk about the latest developments in the use of hydrogen as a main energy source within the global economy.In recent years, the world has committed to the development of a green and sustainable global economy. The Expo has received strong support from HSBC, and has invited Carrie Ng, Head of Sustainable Finance, Commercial Banking, Hong Kong, HSBC; Ophelia Lin, Founder and Managing Director, Meiriki Japan Company Limited; Joy Song, Vice General Manager, CECEP Environmental Consulting Group Limited; Johnny Tam, Co-founder & BIM Scientist, XenseTech, and Jenny Lee, Under Secretary General, Hong Kong Green Finance Association to talk about 'Sustainable Finance in Accelerating the Net Zero Transition: SME and ClimateTech'. The Expo has also invited Max Wong, Managing Director of Project & Operations (HK), Link Asset Management Limited to introduce their latest sustainability initiatives through 'A Real Time Walk to See How We Link Sustainability with Communities'.Japan Pavilion returns to the Expo with largest line-up everThe Expo includes a strong line-up of exhibitors from Mainland China, Singapore and Taiwan in Asia, and exhibitors from France, Germany and Sweden in Europe. Alongside the individual exhibitors, the Canadian and Japanese Pavilions return again this year to showcase their national strengths. The Japan Pavilion (booth 1B-E22&E26) is backed by the Hong Kong Japanese Chamber of Commerce and Industry and the Japan External Trade Organization, featuring the largest line-up ever with 38 exhibitors. Toyota Tsusho HK, a subsidiary of the Toyota Group, introduces ecological and renewable energy technology including developments in hydrogen energy use; YKK Hong Kong showcases environmentally friendly zippers made from plant-based materials, as well as a newly launched waterproof zipper made from recycled polyethylene terephthalate (PET) plastic.The Canada Pavilion (booth 1B-E16) includes exhibitors from the fields of waste treatment, green buildings, solar power generation, and the Internet of Things (IoT). CarbonCure Technologies Incorporated, an exhibitor making its debut appearance at the Expo, introduces its innovative technology for using recycled carbon dioxide to manufacture reinforced concrete."Green Transportation" zone displays single-deck hydrogen energy busThe latest Policy Address mentioned that the HKSAR Government will cease new registration of fuel-powered and hybrid private cars by 2035. The "Green Transportation" zone at the Expo gathers the latest electric vehicles and charging facilities to help the industry seize business opportunities. The largest exhibitor, Wisdom Motors (HK) Limited (booth 1A-C31), displays its single-deck hydrogen energy bus along with the double-decker electric buses serving in Hong Kong to promote carbon neutrality. Richburg Corporation Limited (booth 1B-B32) features its improved and upgraded versions of electric cars in which the battery life and fast charging performance have been greatly improved, allowing an 80% recharge in just 42 minutes.Diverse eco-friendly products lead to a green lifestyleIn the "Eco-friendly Products" zone, Novetex Textiles Limited (booth 1B-A24) introduces its textile recycling system "The Billie System", which converts waste from textiles into high-quality recycled fibres. Combining with raw and recycled materials, the System produces unique recycled yarns to help make the clothing and fashion industries green. In the "Water Treatment and Quality Management" zone, ShaanXi ORCA Electronic Intelligent Technology Co., Ltd (ORCAUBOAT) (booth 1B-C25) presents an unmanned environmentally friendly vessel which can navigate and clean garbage round the clock on a pre-set course."Green Buildings and Energy Efficiency Zone" displays include a small, but high-efficiency generator system developed by Robin Energy Limited (booth 1B-E12), which can generate electricity in light wind conditions, representing a boost to the conversion efficiency of wind energy to electricity; Huawei International Co Limited's (booth 1B-E07) solar energy storage system can switch to backup mode using stored energy in 5 seconds if a power outage occurs at home; and an exterior wall coating based on Japanese rocket and aerospace technology from new exhibitor Nishitani (Asia) Limited that helps buildings block ultraviolet rays to increase building energy efficiency.Green Workshops and other inspiring activities on Public Day to promote a green lifestyleThe last day of the Expo (17 December) will be open to the public for free, with the aim of inspiring individuals to adopt a green lifestyle. The day will offer a series of environmental protection seminars, including ones led by the Environmental Protection Department, 'Reduce Disposable Plastic Tableware at Source' and 'Sharing of the Latest Policies of Environment and Ecology Bureau', as well as a 'Climate Change - Its Causes and Effects' session organised by the Hong Kong Observatory. Green Workshops like 'Pearl Bracelet Workshop', 'DIY Toy Workshop', 'Build Your Own Water Filter STEM Workshop' and immersive activities including virtual reality (VR) experiences, will be held to encourage the public to practise green living and reduce waste proactively.Website: www.ecoexpoasia.comHKTDC Media Room: http://mediaroom.hktdc.comPhoto download link: https://bit.ly/3Wiqsp0About HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on Twitter @hktdc and LinkedIn.Media enquiriesPlease contact the HKTDC's Communications and Public Affairs Department:Clementine Cheung, Tel: +852 2584 4514, Email: clementine.hm.cheung@hktdc.orgEric Wong, Tel: +852 2584 4575, Email: eric.ks.wong@hktdc.org Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More